Wantstats
IndustriesCompaniesCharts & Stats
Leads DBAdvisoryPricingContact us
Login
/Company Profiles

Deep Intelligence Across Industries

All CompaniesFortune 500Aerospace & Defense iconAerospace & DefenseAgricultureAutomotive iconAutomotiveFinancial Services iconFinancial ServicesChemicals & Materials iconChemicals & MaterialsConsumer Goods iconConsumer GoodsEnergy & Power iconEnergy & PowerEquipment & Machinery iconEquipment & MachineryFood & Beverages iconFood & BeveragesHealthcare & Pharma iconHealthcare & PharmaInformation Technology iconInformation TechnologyManufacturing & ConstructionMRO iconMROProfessional Services iconProfessional ServicesSemiconductors

Showing 14441 companies

Arvee

Arvee Laboratories (India) Ltd.

Premium
Information Technology

Arvee Laboratories is a Gujarat-based, promoter-controlled manufacturer of niche aromatic and heterocyclic fine chemicals, operating a single multi-purpose batch plant near Bhavnagar. Its portfolio spans three application families: sulfonated isophthalic "polymer modifiers" (sodium and lithium salts of 5-sulfoisophthalic acid and their esters) that impart cationic dyeability and water dispersibility to polyester fibres, films and resins; nitro-, amino- and hydroxy-isophthalic "contrast media intermediates" that sit upstream of iodinated X-ray/CT contrast agents; and thiophene- and pyridine-based "drug intermediates". The business is small (FY2026 revenue INR 31.5 crore), volatile (revenue has swung between INR 30 crore and INR 61 crore over four years), nearly debt-free, and increasingly export-oriented, with foreign-exchange earnings equal to roughly 28% of FY2026 revenue. A record Q1 FY2027 (revenue INR 17.2 crore) has re-rated the stock, but the company remains a thinly traded, uncovered nano-cap with a non-cooperating credit rating and limited disclosure. --- ### What the company does Arvee Laboratories manufactures and sells specialty and intermediate chemicals produced by multi-step batch synthesis. The company's own statutory description is brief: its FY2026 Board's Report states only that the company "is engaged in Chemicals" and that there has been no change in the nature of business. The segment note in its Q1 FY2027 results describes operations as falling within the chemicals business, now reported across two segments — a "Textile Chemical Segment (Films & Fibre)" and a "Non-textile Segment" (FY2026 integrated filing marked "Multi segment"; Q1 FY2027 segment table). Data vendors that summarise its filings (Morningstar, Wright Research, Musaffa) characterise Arvee as a specialty chemical company organised around three product families — polymer modifiers, contrast media intermediates and drug intermediates — and note that it principally operates in India by location of assets, although its FY2026 foreign-exchange earnings show that a material share of sales is now exported. ### Chemistry and manufacturing capability The company's website lists the unit processes its Bhavnagar plant is equipped to run: nitration, sulfonation, reduction (including catalytic reduction), halogenation, esterification, alkylation, acylation, Hofmann reaction, Grignard reaction, Vilsmeier–Haack reaction, Sandmeyer reaction, caustic fusion and Friedel–Crafts reaction. Equipment disclosed on the website includes approximately 80,000 litres of glass-lined reactor capacity (individual vessels from 1 KL to 6.3 KL), approximately 35,000 litres of stainless-steel reactor capacity (0.5 KL to 6.5 KL), more than 8,500 litres of simultaneous centrifugation capacity, more than 6,000 litres of agitated Nutsche filtration capacity, stainless-steel distillation columns, and rotocone vacuum, fluidised-bed and tray dryers, supported by boilers, chilling and brine plants, cooling towers, power generation, DM water, vacuum systems and an effluent treatment plant. This is the profile of a classic Indian "multi-purpose intermediates" plant: a modest total reactor volume (roughly 115 KL) that can be re-configured across many chemistries, which allows a broad catalogue but limits scale economics in any single molecule. ### Business and revenue model | Revenue model component | Assessment | Basis | |---|---|---| | Product sales (manufactured goods) | Essentially 100% of revenue | All reported revenue is "revenue from operations" from chemical sales; no service, licensing or subscription revenue is disclosed | | Services / tolling / custom synthesis | Not separately disclosed | The company's origins involved job-work arrangements (see Section 3), but no current tolling revenue is reported | | Licensing / royalties | None disclosed | — | | Subscription | Not applicable | — | | Other income | INR 0.69 crore in FY2026 (about 2% of revenue) | FY2026 Annual Report | Sales are business-to-business, made to manufacturers rather than end consumers. Pricing is not disclosed; as a commodity-linked intermediate producer, pricing is likely negotiated per order or per contract with exposure to input-cost pass-through, but this is an analytical inference, not a disclosed fact. ### Value-chain position Arvee sits in the middle of the chemical value chain. Upstream, it buys aromatic and heterocyclic feedstocks (isophthalic acid derivatives, thiophene, pyridine and related raw materials, plus acids, alkalis and solvents); its FY2026 foreign-exchange outgo on imported raw materials was INR 7.38 crore against total raw material consumption of INR 18.19 crore, implying that roughly 41% of materials consumed by value were imported (FY2026 Annual Report; analytical calculation). Downstream, its outputs are consumed by: - polyester fibre, film and resin producers (polymer modifiers for cationic-dyeable polyester, water-dispersible polyester, textile sizing, spin finishes); - manufacturers of iodinated contrast media active ingredients, through their intermediate supply chains (contrast media intermediates); - pharmaceutical API and advanced-intermediate manufacturers (drug intermediates); - per CRISIL, also customers in fertiliser and "other" industries. ### Customer types and end-markets | End-market | Products relevant | Disclosure status | |---|---|---| | Textiles / polyester fibres and films | DMS/Na-SIPA/Li-SIPA/SIPHE-40 polymer modifiers | Named application areas disclosed (prospectus, website); customer names not disclosed | | Medical imaging (iodinated contrast agents) | 5-NIPA, DM-5-NIPA, MM-5-NIPA, 5-AIPA, dimethyl 5-AIPA, 5-HIPA, 3,5-DNBA, 3,5-diaminobenzoic acid | Application disclosed; customer names not disclosed | | Pharmaceuticals | 2-acetylthiophene, thiophene-2-carboxaldehyde, 4-aminopyridine, 2-chloro-5-nitrobenzoic acid | Application disclosed; customer names not disclosed | | Fertilisers and other | Not specified | CRISIL description | Customer concentration: not publicly disclosed in the sources reviewed. Given the company's size and the niche nature of each molecule, meaningful concentration is likely, but no figures are published. ### Independent characterisation Arvee is best characterised as a sub-scale, owner-managed, multi-product intermediates manufacturer whose earnings are highly sensitive to a small number of orders and to working-capital swings. Its competitive "moat", to the extent one exists, lies in process know-how for a set of low-volume molecules (notably SIPA salts and nitro-isophthalic contrast-media precursors) where global buyer pools are concentrated and qualification cycles create some stickiness. Against that, there is no disclosed R&D spend, no patent portfolio, a single plant, and a revenue history that has gone sideways for nearly a decade (FY2016 revenue INR 26.8 crore; FY2026 revenue INR 31.5 crore; ten-year sales CAGR of about 2% per Screener).

Revenue$0.0B
Employees65
Market CapN/A
Founded2012
Ahmedabad, India

Unlock Verified Contacts

Access verified employee contacts

Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.

USD650/mo
Buy Now

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
MR
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
BL
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
MI
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
RK
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
JL
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
AM
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Wantstats logo

Move faster. Think smarter. Win bigger.

Join our data driven community.

© 2026 All rights reserved by Wantstats Research and Media Pvt Ltd

footer vector

Pages

  • About
  • News
  • Charts & Stats
  • Contact
  • Ecosystem pricing
  • Privacy policy

Address

Wantstats Research and media Pvt. Ltd, Office No 104, Pentagon 4,
Magarpatta City, Pune - 411028,
Maharashtra, India.

Contact

support@wantstats.com

Follow Us

Follow Wantstats on FacebookFollow Wantstats on InstagramFollow Wantstats on LinkedInFollow Wantstats on YouTubeFollow Wantstats on WhatsApp
Pasura

Pasura Industries Limited

Premium
Information Technology

| Metric | FY2024 | FY2025 | FY2026 | |---|---|---|---| | Employees (number) | — | 53 | 166 | | Employee benefit expense (INR Lakh) | — | 134.72 | 1123.49 | Sources: TradingView (headcount, FY2026 with YoY change); ScanX summary of FY2026 audited results (employee expense). FY2024 not publicly disclosed. FY2025 headcount is implied by TradingView's reported change and is not separately verified. Pasura Industries Limited is a Hyderabad-based micro-cap that has turned itself from a dormant shell into a contract beverage manufacturer within roughly four years. Under the Century 21st Portfolio and early Arunjyoti names, it traded equities, commodities, fertilisers and agri-inputs. Control changed in 2022, when the Pabbathi family acquired the promoter stake and made an open offer. The company then borrowed heavily to build two filling plants, one in Telangana and one in Andhra Pradesh, and in 2024 raised INR 33.13 Cr through a rights issue. It now operates a single segment: co-packing packaged drinking water, fruit-based drinks and other ready-to-drink products, plus a newly launched jelly-pouch line. Its anchor customer is Tata Consumer Products Limited, which has placed dedicated machinery in both plants. Revenue has levelled off at about INR 28 Cr. Profitability is fragile, liquidity is thin, governance is promoter-dominated, and the shareholder base has become heavily retail. --- ### What the company does Pasura Industries is a contract manufacturer ("co-packer") of non-alcoholic beverages and related ready-to-consume products. Brand owners, chiefly a large Indian FMCG multinational, supply or specify formulations, packaging specifications and, in some cases, dedicated machinery. The company provides processing, filling, packaging and associated logistics from its own plants. It does not own consumer brands. According to the company website, its services include: **Beverage co-packing:** non-carbonated drinks, juices and energy drinks. **Non-carbonated (packaged drinking) water production:** the plant follows Bureau of Indian Standards (BIS) parameters and holds Food Safety and Standards Authority of India (FSSAI) licences. **Retail/distribution services:** the company describes itself as an authorised distributor for several FMCG multinationals in Telangana, with a state-wide distribution network. The FY2026 Annual Report, as summarised by Screener.in's document extraction, describes the company as a beverage co-packing and packaging business. It offers end-to-end manufacturing, processing, filling and packaging for packaged drinking water and fruit-based beverage brands. In FY2026 this included beverage processing and co-packing for Tata Consumer Products Limited (TCPL). ### Company's own description (paraphrased from website and annual report summaries) The company presents itself as a dependable co-packer of beverages for a multinational customer. It cites state-of-the-art facilities in Telangana and Andhra Pradesh, a skilled workforce, careful selection of raw and packaging materials from trusted vendors, and environmentally responsible practices. Its pitch to brand owners is that outsourcing packaging lets a manufacturer focus on core competencies while saving on packaging machinery, labour and logistics. The website slogan is that the company helps "elevate your brand, one bottle at a time." ### Business model and revenue model | Revenue stream | Nature | Disclosed share of revenue | Comment | |---|---|---|---| | Co-packing / job-work for MNC brand owners | Service (conversion fee and/or product sale on a cost-plus basis) | Not publicly disclosed; company reports a single segment | Screener lists "jobwork revenue share" as an AR-extracted metric (premium-gated) | | Own-account packaged drinking water / beverages | Product sale | Not publicly disclosed | The website refers to a non-carbonated water plant; whether any volume is sold under own or third-party labels is not disclosed | | Retail / FMCG distribution in Telangana | Trading / distribution margin | Not publicly disclosed | Website claim; not separately reported | | Subscription / licensing | None | 0 | Not applicable | **Independent characterisation.** Economically, the business is a capacity-rental model for one dominant customer. Revenue depends on the customer's seasonal RTD and water demand allocated to these plants. Margin depends on capacity utilisation, the conversion fee and the company's control of consumables and wastage. TCPL's provision of INR 8.9 Cr of dedicated machinery (December 2024) is typical of a captive contract-manufacturing relationship. It lowers the company's capital burden but deepens dependence. Management itself attributed the FY2026 losses to "under-utilisation of manufacturing capacity", abnormal inventory consumption and higher operating costs. All three are classic co-packer risks. ### Value-chain position | Value-chain stage | Who performs it | Company involvement | |---|---|---| | Brand ownership, marketing, distribution | Brand owner (e.g., TCPL) | None | | Formulation / concentrate supply | Brand owner | Receives inputs | | Water treatment, processing, mixing | Co-packer | Yes | | Filling (PET bottles, pouches), capping, labelling | Co-packer | Yes | | Secondary packaging, warehousing | Co-packer | Yes; Jangaon warehouse acquired August 2025 | | Primary logistics to brand owner's network | Shared / brand owner | Partial (not disclosed) | | Regional distribution (Telangana) | Distributors | Website claims authorised-distributor role | ### Customer types and end-markets **Customer type:** large FMCG corporates. The company's own materials refer to "a multinational corporation" in the singular and to "MNC partners". **Named customer:** Tata Consumer Products Limited, confirmed through BSE disclosures of 24 December 2024 (machinery arrangement) and 10 March 2026 (jelly pouch line). **End-markets:** Indian packaged drinking water, ready-to-drink fruit beverages, energy/glucose drinks and ready-to-eat fruit jelly (from March 2026). Sales are domestic only.

Revenue$0.0B
Employees166
Market CapN/A
Founded1986
Hyderabad, India
ArunaHotels

Aruna Hotels Limited

Premium
Information Technology

Aruna Hotels Limited is a 66-year-old Chennai company that has shed its original sugar, flour-milling and chemicals businesses. It is now a pure-play, single-asset hotel owner-operator. Its only operating asset is the 82-room Pharos Hotels, which includes five suites. The hotel is a business-class property on Sterling Road in Nungambakkam, close to several consulates, the US biometric centre and visa-application centres, and that location drives a steady stream of documentation-related and corporate demand. After a long dormancy and renovation (FY2017–FY2022, with near-zero operating revenue), the hotel reopened in November 2022. Revenue reached INR 25.1 crore in FY2026 and operating margins expanded to about 24.5%. The company remains heavily leveraged, with roughly INR 118 crore of borrowings against about INR 28 crore of net worth, and its reported profits are thin and volatile. Its equity story rests on the ramp-up of the hotel, the newly renovated Annex Building (banquets plus leasable office floors), and the value of its central-Chennai land. --- **What the company does.** Aruna Hotels describes its objects as developing, owning, acquiring, renovating, operating, managing and promoting hotels and restaurants. In practice it owns and operates a single hotel, Pharos Hotels, at 144–145 Sterling Road, Nungambakkam, Chennai. The FY2025 Directors' Report states that the hospitality business is run under the brand "Pharos Hotels", a unit of Aruna Hotels Limited. Data providers (MarketScreener) also describe the business as hotel and restaurant operation plus property rental and laundry services. **Company's own description (latest annual report, FY2025, paraphrased).** The FY2025 annual report, the 63rd, was filed on 1 September 2025. It presents the year as a turnaround: profit before tax was INR 16.18 lakh against a loss of INR 373.81 lakh in FY2024. Management attributes this to streamlined operations, cost optimisation and better guest experience, alongside continued governance compliance and resolution of shareholding and dispute matters. Its reported content includes the MD reappointment and an independent-director appointment. **Business model and revenue model.** The model is entirely service-based (hospitality), with a growing real-estate rental component. There is no product, subscription or licensing revenue. **Value-chain position.** Aruna is an *asset-owner-operator*. It owns the land and building and runs the hotel under its own brand, Pharos, without a third-party management contract or franchise. In FY2011 the company had a marketing tie-up with Fortune Park Hotels Ltd (an ITC Hotels subsidiary) for the earlier "The Aruna Chennai" hotel. No current brand affiliation is disclosed. **Customer types and end-markets.** **Documentation and consular travellers:** The hotel is about 1 km from the US, Sri Lankan, Belgian, Singapore, Australian and New Zealand consulates, and within roughly 10 minutes of the US biometric centre, the British Deputy High Commission, the UAE attestation centre and VFS Global (company description reproduced on Upstox). **Domestic corporate travellers:** visiting Chennai's central business district. **Social and corporate events:** (banquets, conferences). **Commercial tenants:** (office lease in the Annex). **Independent characterisation.** Aruna is best understood as a *leveraged real-estate holding with an operating hotel attached*. The hotel now produces positive operating cash profit, with EBITDA excluding other income of INR 6.16 crore in FY2026. Reported net earnings, however, are dominated by large, roughly offsetting year-end entries in "other income" and "finance cost" (about INR 13–14 crore each, booked in Q4 of FY2024, FY2025 and FY2026), and by volatile tax charges. The investment case therefore rests on four things: asset value, RevPAR ramp-up, the resolution or refinancing of its roughly INR 118 crore of related-party-type borrowings, and new rental income from the Annex.

Revenue$0.0B
Employees14
Market CapN/A
Founded1960
Chennai, India
Artson

Artson Limited

Premium
Information Technology

Artson Limited is a micro-cap Indian engineering, manufacturing and construction (EMC) contractor, 75% owned by Tata Projects Limited. It has spent four decades building large-diameter bulk liquid storage tanks for refineries, terminals and airports. It is now turning itself into a three-engine business: precision process-equipment manufacturing at Nashik, heavy structural and modular fabrication at Parli (Raigad), and shipbuilding / hull-block fabrication for yards such as GRSE and Mazagon Dock. FY2026 revenue of INR 163.58 Cr was the highest in the decade. It nonetheless produced a INR 10.88 Cr net loss, because management chose to write down legacy projects and rebuild its factories. The balance sheet is thin, with near-zero net worth and about INR 53 Cr of borrowings, much of it interest-free parent debt. That makes TPL's support the central credit and equity variable. The investment case depends on three things: converting new capability into profitable throughput, recovering legacy claims, and executing on India's shipbuilding and industrial capex cycle. Execution consistency has historically been weak. --- ### Company's own description (FY2026 Annual Report, paraphrased) The FY2026 Board's Report describes the core business as: - manufacturing process plant equipment; - fabricating structures; - fabricating and erecting hull blocks and shipbuilding with associated works; - constructing storage tanks. It states that this basic nature of business did not change during FY2026. Since FY2026, management runs the company as three empowered Strategic Business Units (SBUs): **Manufacturing:** Nashik process equipment and Parli multimodal structural fabrication. **Projects, Tankage & EPC:** - Shipbuilding. Three corporate functions and a six-member executive committee support the SBUs. The Whole-Time Director & CEO also holds the Chief Operating Officer remit (FY2026 AR, CEO letter). ### Independent characterisation | Revenue model element | Characterisation | Evidence | |---|---|---| | Product (engineered-to-order manufacturing) | Growing; Nashik and Parli deliveries billed per item or tonne | Item-rate orders: Deepak Chem Tech, L&T-MHI, Anuppur (2026 filings) | | Service / construction contracts | Historically dominant (tankage LSTK/EPC); now deliberately capped | CEO letter: prefers 4–5 live projects of INR 30–150 Cr | | Subscription / licensing | None today. Management is pursuing inbound manufacturing licences from European/North American OEMs. | FY2026 AR, "New Product & Licensing Initiatives" | | Claims revenue | Material and lumpy, e.g. INR 9.92 Cr claim revenue recognised in Q2 FY27 | Q2 FY27 results, 16 Oct 2026 | Artson is a project-based, order-driven fabricator and contractor. Revenue comes from fixed-price or item-rate contracts, recognised over time as work progresses. It is not a product company in the catalogue sense. Nearly all output is bespoke and engineered-to-order: pressure vessels, heat exchangers, storage tanks, steel structures, pontoon panels and hull blocks. **Value-chain position.** Artson sits at the tier-2 fabricator / tier-1 package-contractor level: **Upstream:** buys steel plate, pipe and consumables. Management cites supply-chain synergies with Tata Steel. **Downstream:** sells to EPC majors such as TPL, L&T-MHI Power Boilers, TKIL Industries, Danieli Corus and Andritz. It also sells to owners and operators: IOCL, Reliance, Hindalco, Adani Power, Deepak group, Navin Fluorine, Shell India, GMR/Guwahati airport, and shipyards GRSE, Mazagon Dock and Sadhav Offshore. **End-markets served:** - oil refining and petrochemicals; - fertiliser and chemicals (ammonia); - power (thermal coal-handling plants, boiler vessels); - metals (blast furnaces, aluminium); - airports (aviation fuel farms); - defence and research shipbuilding; - infrastructure (ports, airports, data centres as a target); - emerging energy-transition demand (green hydrogen and ammonia storage, as a stated target). **Customer types:** - the related-party parent (TPL), which places EPC and structural orders; - public-sector undertakings (IOCL, GRSE, Mazagon Dock); - large private industrials; - global EPC/OEM contractors. TPL dependence is structural. Shareholders approved related-party transactions with TPL of up to INR 320 Cr a year (INR 300 Cr for goods, services, loans and credit; INR 20 Cr for property) at the 47th AGM on 25 Sep 2026.

Revenue$0.0B
Employees159
Market CapN/A
Founded1978
Hyderabad, India
Artemis

Artemis Electricals and Projects Limited

Premium
Information Technology

Artemis Electricals and Projects Limited is a Thane-based micro-cap that began life in 2009 as a designer, OEM manufacturer and trader of LED luminaires — street lights, solar lighting systems, panel lights, downlights, garden and pathway lights and flashlights — supplying OEM partners (an earlier annual report names Bajaj) and its own brand through roughly 62 distributors across five Indian states. Following a sharp pandemic-era collapse in product revenue and a FY2022 loss, management has repositioned the company as a project-driven Engineering, Procurement and Execution (EPE/EPC) and turnkey electrical infrastructure contractor that also undertakes specialised Mechanical, Electrical and Plumbing (MEP) work for government infrastructure, smart city, hospitality, commercial real estate, residential township and industrial clients. Revenue is now small (INR 80.56 crore in FY2026), lumpy by quarter, highly concentrated (a promoter-group construction company is disclosed as the top customer) and near debt-free. Two long-dated optionalities — a lithium-ion battery plant and an Electronics Manufacturing Cluster SPV — remain uncommissioned. --- ### The company's own description In its Q1 FY2027 earnings presentation (filed with BSE/NSE on 14–15 August 2026), Artemis describes itself as a project-driven Engineering, Procurement and Execution (EPE) and turnkey electrical infrastructure company delivering end-to-end electrical and infrastructure projects across India, which also undertakes specialised MEP work. The presentation states that the company evolved from a product/OEM-oriented electrical solutions provider into a full-scale project execution organisation, and frames the shift from an "O&M/OEM" model to an EPC model as a response to margin erosion and competition in the earlier model, with the stated benefits being single-point accountability, better execution control and improved profitability potential (Investor Presentation Q1 FY2027; Multibagg AI and FilingReader summaries). Earlier annual reports (FY2023 annual report as summarised by Screener.in) described the business as product design, procurement, turnkey manufacturing, repairs and maintenance, positioning the company as an OEM focused on LED lighting and allied products, supplying OEM partners such as Bajaj, marketing its own brand through stockists, distributors and retail chains in five states via 62 distributors, and actively pursuing export markets. Third-party databases still classify the company on its legacy activity: Morningstar describes it as manufacturing and trading LED lights and accessories — indoor and outdoor luminaires including street lights, solar-powered home LED lighting systems, downlights, garden lights and pavement/walkthrough indication lights — operating only in India. MarketInOut adds that the company also takes on electrical work contracts and supplies residential, commercial and government customers. The MCA registry lists the main line of business as wholesale trade and commission trade (InstaFinancials). ### Independent characterization On the evidence of the FY2025–FY2026 numbers and the auditors' remarks, Artemis today is best understood as a small, asset-light electrical/MEP contracting business layered on top of a largely idle LED manufacturing facility: **Manufacturing has been negligible:** The statutory auditor's report on FY2026 (as summarised by ScanX, 30 May 2026) notes that manufacturing activities at the factory premises were closed or negligible, with only minimal activities having commenced, as management focuses on projects. Inventory is correspondingly tiny (INR 0.51 crore at 31 March 2026 per StockAnalysis), and inventory days were 17 in FY2026 (Screener). **Revenue is project-billed and lumpy:** Quarterly revenue has swung between INR 2.46 crore (Q4 FY2024) and INR 40.75 crore (Q4 FY2026), which is characteristic of milestone billing on a handful of contracts rather than of a distribution-led lighting business. **Customer concentration with a related party:** Screener's annual-report extraction carries a field titled "Top Customer (Garuda Construction) Revenue Share", identifying Garuda Construction and Engineering Ltd. — a listed construction company whose Chairman and Managing Director, Pravinkumar Brijendra Kumar Agarwal, is also an individual promoter of Artemis — as the largest customer. The exact share is not visible in the public tier of the source. Related party transactions were put to a shareholder vote at the 16th AGM (27 September 2025), with promoter-group votes excluded (FilingReader). **Working capital is financed largely by suppliers:** Days payable reached 1,323 in FY2026 against debtor days of 179, producing a deeply negative cash conversion cycle of −1,127 days (Screener, FY2026). This is unusual and implies that payables (INR 38.79 crore at FY2026) are being settled on very extended terms; the counterparties are not disclosed in sources reviewed. **Optionalities:** A lithium-ion battery plant at the Artemis Complex (capital work-in-progress) and an Electronics Manufacturing Cluster (EMC 2.0) SPV through subsidiary Artemis Opto Electronic Technologies Pvt. Ltd. are the stated growth bets; neither has a disclosed capex budget, capacity or revenue timeline. ### Revenue model | Revenue model element | Description | Disclosure status | |---|---|---| | Project / work-contract revenue (EPC, MEP, electrical works) | Milestone-billed contracts for electrical infrastructure, MEP and turnkey works | Share of revenue not publicly disclosed (Screener shows a "Work Contract Income Proportion" field behind a paywall) | | Product sales (LED luminaires, solar lighting) | Own-brand and OEM supply of LED lighting | Share not publicly disclosed; auditor indicates manufacturing negligible in FY2026 | | Trading | Purchase and resale of lighting/electrical items | Not separately disclosed | | Services / O&M | Repairs and maintenance (legacy) | Not separately disclosed | | Subscription / licensing | None identified | — | ### Value-chain position, customers and end-markets Artemis sits at the execution and integration layer of the electrical value chain: it procures components (luminaires, cables, switchgear, panels and similar items — exact bill of materials not disclosed), engineers and installs them, and commissions systems. It does not appear to own differentiated component IP. The company lists its operating focus as government and public infrastructure projects, smart city works, hospitality and commercial real estate, residential townships, and industrial and institutional electrical infrastructure (Investor Presentation Q1 FY2027). Its historical lighting customer base spanned residential, commercial and government buyers, including roads, civic centres, offices and public spaces (MarketInOut). Geographically, all disclosed activity is in India.

Revenue$0.0B
Employees23
Market CapN/A
Founded2009
Thane, India
Artefact

Artefact Projects Limited

Premium
Information Technology

- The company's own website timeline places the BSE listing in 1995. - Simply Wall St (from S&P data) shows equity listed on BSE from July 2005. - GuruFocus shows an "IPO date" of 11 September 2000. The 1995 date from the company is treated as authoritative. The later dates probably reflect changes to demat or trading status. Artefact Projects Limited is a Nagpur-headquartered infrastructure consultancy with almost four decades of corporate history. It earns essentially all of its revenue from engineering, architectural and project-management consultancy for Indian public infrastructure, mainly national highways. The company's main franchise is in Independent Engineer (IE), Authority's Engineer (AE) and Supervision Consultant (SC) mandates from the National Highways Authority of India (NHAI). These are multi-year, fee-based contracts, typically 36–60 months, covering projects in the construction or operation-and-maintenance (O&M) phase. They are usually won in joint ventures or associations with domestic and international consultancies. The company is very small: FY2026 revenue from operations was ₹32.25 cr and the market capitalisation is about ₹35 cr. It trades at roughly half of book value and has been consistently profitable since FY2019. Its weaknesses are concentration on a single customer, receivables that are slow to convert to cash, and persistently negative operating cash flow. In September 2026 the company won its first railway project-management mandate, worth ₹21.13 cr, from South Central Railway. This is a strategic step toward diversifying away from highways. --- ### The company's own description The company's FY2025 annual report (BSE, cited via Screener) describes the business as project consultancy undertaken as consulting engineers, architects and planners. The company's 2026 website describes Artefact as a premier infrastructure consultancy with more than three decades of work across India. It says the firm specialises in highways and transportation infrastructure, provides services spanning engineering, planning, design and project management, and serves government agencies and industry stakeholders end to end. The company's standard press boilerplate, carried in Capital Market–Live News syndications, describes it as providing engineering, architectural and project-management services for infrastructure projects, "especially highways". The boilerplate also claims a global presence through collaboration with international consultants. Older company profiles (MarketsMOJO "Company CV") list five service sectors: - Highways - Urban infrastructure - Airports - Mining services - Railways ### Independent characterisation In practice Artefact is a highway-supervision fee business. Nearly all of the order inflow disclosed between 2024 and 2026 comes from NHAI. The disclosed contracts are mostly of two kinds: **Independent Engineer (IE) services:** These cover Build-Operate-Transfer (BOT) and Hybrid Annuity Model (HAM) concessions in their construction and O&M periods. The IE is a neutral engineer appointed jointly under the concession agreement who certifies milestones, completion and O&M compliance. **Supervision Consultant (SC) / Authority's Engineer services:** These cover Engineering, Procurement and Construction (EPC) projects and their O&M phases, where the consultant acts for NHAI. Contract values per mandate are small, typically ₹2.5–8 cr for Artefact's share, and run for 36–60 months. Revenue is therefore recognised as a fairly smooth stream of monthly fees. However, the stream is lumpy at the quarterly level because of milestone billing and approval cycles. Q4 is consistently the strongest quarter: ₹12.74 cr in Q4 FY2025 and ₹14.33 cr in Q4 FY2026, compared with ₹2–3 cr in Q1. ### Business model and revenue model | Dimension | Characterisation | |---|---| | Revenue type | 100% services. Consultancy fees are billed as man-month based or lump-sum retainers under consultancy contracts. There is no product, subscription or licensing revenue. | | Pricing mechanism | Competitive tendering, typically Quality and Cost Based Selection (QCBS) under NHAI/MoRTH procurement rules. Artefact frequently discloses awards as H1 (highest-ranked) bidder. | | Contract tenure | 24–60 months. Examples: 60 months for the Sethiyathope–Cholapuram and Vadodara–Kim IE mandates; 36 months for Thoppur–Erode; 24 months for the SCR railway PMS. | | Delivery model | Often in joint venture or association with partners: Pioneer Infra Consultants, KCS Engineering, Mangalam (Manglam) Infra & Engineering, Renaissance IOT LLP, Neoteric LLP, MSV International Inc., Sunnily Consultants and Desh Upodesh. Artefact's share of fees is what it discloses. | | Cost structure | Mainly professional staff costs and site establishment (field engineers, resident engineers, team leaders), plus sub-consultancy and travel. Gross margin (S&P definition) ranged from 27% to 36% between FY2022 and FY2026. | | Value-chain position | Owner's-side / independent technical oversight. Artefact does not construct; it certifies, supervises and advises on construction and O&M by EPC/HAM/BOT concessionaires. | | Customer types | Central government road-owning agencies (NHAI, and historically MoRTH and state PWDs such as PWD Rajasthan, Jaipur). Historically also Airports Authority of India (AAI, first airport PMC in 2007) and, from 2026, Indian Railways (South Central Railway). | | End-markets | National highways (dominant), expressways (Bharatmala Pariyojana), urban infrastructure and township planning (historical), airports (historical), railways (new in 2026). | ### Non-operating income "Other income" is large relative to operating profit. It ranged from ₹3.53 cr to ₹5.51 cr a year between FY2022 and FY2026, and in FY2023 it exceeded operating profit. S&P classifies most of it as "interest and investment income" (₹38.89 M in FY2026). It most likely represents interest on deposits, retention monies and receivables, and possibly lease income from the Artefact Towers property. The breakdown is not disclosed in the sources accessed.

Revenue$0.0B
Employees303
Market CapN/A
Founded1987
Nagpur, India
ARTNIRMAN

ART NIRMAN LTD

Premium
Information Technology

Art Nirman Limited is a micro-cap, single-city real-estate developer and construction contractor headquartered in Ahmedabad, Gujarat, controlled by the Thakker family (promoter group 73.75%). It reports one segment, "Real Estate", entirely within India. Since its 2016 SME IPO, the company has evolved from developing its own branded "Shree Vishnudhara" residential-cum-commercial schemes (Cross Road, Gardens) toward a hybrid model in which most revenue now comes from works contracts executed for promoter-linked entities (Club Babylon for Art Club Pvt Ltd; Shree Vishnudhara Essence for Vishnudhara Paradise LLP) and from public-private-partnership redevelopment of old government housing in Naranpura (the Nidhi Apartment HIG schemes). FY2026 revenue was INR 332.4 M with net profit of INR 5.2 M. In FY2026 the company sharply increased leverage (debt/equity 1.96x versus 0.48x) to fund inventory for the redevelopment pipeline, making execution, related-party governance and refinancing the defining investment questions. --- ### Company's own description The FY26 Board's Report and Management Discussion & Analysis describe the company as being engaged in the business of real estate development and allied activities, operating in a single segment — construction of residential and commercial schemes — and carrying on all operations in India, so no geographic segment disclosure is presented [AR FY26; Res Q4FY26 note 4]. The CMD's letter frames FY26 as a year in which the company became operationally stronger, completed ongoing projects to plan, earned revenue from existing projects, and began focusing on bidding for government tenders for different types of projects [AR FY26, Letter to Stakeholders]. The annual report's cover theme is "Disciplined Growth, Proven Execution, Lasting Value" [AR FY26]. The company also states that it has no manufacturing plant or factory, does not conserve energy or absorb technology in the manufacturing sense, and has no foreign-exchange inflow or outflow [AR FY26]. Its corporate-governance section notes that directors' site visits include knowledge-sharing on the pre-cast construction technology the company uses [AR FY26, CG Report — Familiarisation Programmes]. ### Business model and revenue model | Revenue model | Description | Evidence | Approx. share of FY26 revenue | |---|---|---|---| | Works-contract construction for related parties | Construction services billed to promoter-linked entities (Art Club Pvt Ltd for Club Babylon; Vishnudhara Paradise LLP for Shree Vishnudhara Essence; Ohm Enterprise for Omkar Enclave) | AR FY26 Board's Report; AOC-2 | Club Babylon INR 74.9 M + Essence INR 97.5 M = INR 172.4 M (≈52%) — plus any related-party share of "other works contracts" | | Other works contracts (counterparties not itemised) | "Different projects" executed under works contracts | AR FY26 | INR 156.6 M (≈47%) | | Own development / redevelopment (product sales) | Sale of residential flats and shops in own or PPP redevelopment schemes (Shree Vishnudhara Nidhi, Residency, Nandi, Ashiyana) recognised as projects progress or complete | AR FY26 MD&A; RERA | Residual; most FY26 redevelopment activity sits in inventory (INR 754.1 M) rather than revenue | Art Nirman's revenue derives from three overlapping models, none of which is subscription or licensing-based: Note: the three disclosed buckets (INR 74.9 M + INR 97.5 M + INR 156.6 M = INR 329.0 M) reconcile to within INR 3.4 M of reported FY26 revenue from operations of INR 332.4 M [AR FY26; Res Q4FY26]. ### Value-chain position The company occupies the developer-contractor position in the residential and commercial real-estate value chain: land/development rights are typically obtained via development agreements (including with promoter LLPs such as Vishnudhara Developers LLP for Ashiyana) or through PPP redevelopment rights over government housing land; the company then designs (with consultants), obtains approvals (RERA, building-use "BU" permission), constructs (in-house execution with subcontracted labour and purchased materials) and sells or hands over units. It does not manufacture building materials, does not operate rental assets, and has no asset-management or facility-management arm. The Club Babylon project is a construction engagement; the club itself is not owned by Art Nirman [AR FY26 MD&A]. ### Customer types and end-markets | Customer type | End-market | Example | |---|---|---| | Promoter-linked developers/operators (B2B) | Hospitality/leisure club construction; mid-to-premium residential construction | Art Club Pvt Ltd (Club Babylon); Vishnudhara Paradise LLP (Essence, Thaltej) | | Government housing authority / existing residents (PPP) | Redevelopment of dilapidated public housing (High Income Group flats) | 100 HIG + 60 shops and 24 HIG Nidhi Apartment, Naranpura (PPP basis) | | Retail homebuyers (B2C) | Premium 3 BHK and 4 BHK apartments in western Ahmedabad; commercial shops/showrooms | Shree Vishnudhara Residency (136 free-sale 3 BHK + 3 shops); Shree Vishnudhara Nandi (70 4 BHK) | | Retail commercial buyers | Shops/showrooms in mixed-use schemes | Shree Vishnudhara Ashiyana (83 commercial + 6 flats) | ### Independent characterisation On the evidence of FY26 filings, Art Nirman is best characterised as a promoter-group construction vehicle that is transitioning into a leveraged PPP redevelopment developer. Three features dominate: (1) concentration — every disclosed project is in Ahmedabad, and the majority of disclosed FY26 revenue came from entities in which the CMD is a partner, designated partner or director; (2) balance-sheet transformation — total assets roughly doubled from INR 688.2 M to INR 1,423.7 M in FY26, with inventory up INR 331.9 M and borrowings up INR 549.1 M; and (3) thin earnings — operating EBITDA margin improved to 15.0% but finance costs of INR 41.9 M absorbed almost all of it, leaving net profit of INR 5.2 M [Res Q4FY26; SA]. The model's value creation therefore depends on converting the Naranpura redevelopment inventory into sales at margins that exceed a now materially higher cost of capital.

Revenue$0.0B
Employees20
Market CapN/A
Founded2011
Ahmedabad, India
ARSS

ARSS Infrastructure Projects Limited

Premium
Information Technology

ARSS Infrastructure Projects is a small Odisha-based civil EPC contractor. It began in 2000 as a stone-crushing and railway-earthwork business and grew into a mid-sized builder of railway track, bridges, road over-bridges (ROBs), state highways and irrigation works, mainly for Indian Railways zones and Odisha state agencies. Revenue peaked above INR 1,100 Cr around FY2012, three years after a 47-times-oversubscribed IPO. A decade of over-leverage, receivable disputes and losses then followed, ending in insolvency in November 2021. The NCLT-approved plan of August 2025 wrote off roughly 96% of INR 5,314 Cr of admitted claims and transferred control to Ocean Capital Market, the vehicle of iron-ore miner Dipti Ranjan Patnaik. The company now combines a small operating business (FY2026 revenue INR 146 Cr; order book about INR 952 Cr at Dec 2025) with a large portfolio of disputed arbitration claims. Its investment case rests almost entirely on whether execution and claim recoveries come through, and on governance under the new owner. --- **What the company does.** ARSS is a construction contractor. It bids in public tenders for item-rate and EPC contracts and builds civil infrastructure for government owners. The company describes its core skill as railway construction: - formation earthwork - major and minor bridges - supply of ballast and sleepers - laying of sleepers and rails, and track linking Around this core it has added roads and highways, bridges and flyovers, irrigation projects and EPC work for railways (Company business overview, as reproduced by Screener). Exchange-sourced profiles add more detail on railway services: - surveying, alignment and design of roads and railways - embankments and cuttings - road and rail bridges - fabrication and erection of steel girders - in-situ flash-butt welding of long rails - yard signalling and electrification The same profiles also list urban, marine and power projects (Zonebourse/Investing.com company descriptions). An aggregator profile mentions irrigation hydro-mechanical work: design, supply and erection of radial gates and hoist bridges on trestles (Upstox profile). **Self-description in the latest filings.** The FY2025 Directors' Report, issued during the insolvency process, calls the company a well-known name in Indian infrastructure. It records consolidation of a subsidiary toll company, an associate and about fifteen project joint ventures. In FY2025 XBRL filings the company reports a single segment, "Infrastructure / Constructions" (NSE XBRL, results of 28 May 2025). Infomerics (20 Mar 2026) describes ARSS as a Bhubaneswar-based infrastructure and construction company working in railways, roads, bridges and irrigation across India, supported by multiple crushers and hot-mix and wet-mix plants in Odisha. **Business model and revenue model.** Revenue is almost entirely contract service revenue recognised over time on construction contracts. Morningstar notes that most revenue comes from the sale of services. The model has four parts: **Order acquisition:** Competitive public tenders, standalone or through project-specific JVs. ARSS won its June 2026 Jagatsinghpur road contract at INR 21.47 Cr against a departmental estimate of INR 29.82 Cr, about 28% below estimate (Trade Brains, 24 Jun 2026). This shows the aggressive pricing typical of state-plan road tenders. **Execution:** Self-perform earthwork, aggregates (captive crushers), bituminous and wet-mix works, and structures. Specialised scope is subcontracted. The forensic transaction audit showed that railway work allotted by RVNL was at one point paid directly into a subcontractor's account (NCLT order para 20). **Escalation and claims:** Contracts generally carry price-variation clauses (Infomerics). Disputes over delay, scope variation and escalation have historically become arbitration claims. These claims are now the largest asset on the balance sheet. **Ancillary:** Toll revenue from the subsidiary ARSS Damoh-Hirapur Tolls Pvt Ltd. Historically, crusher plants were rented to a related party (NCLT order, transaction-audit findings). **Revenue mix by type.** The company does not disclose a split between product, service, subscription and licensing revenue. In substance, more than 95% is contract revenue, with small toll and other operating income. **Value-chain position.** ARSS is a tier-2/tier-3 civil contractor. It sits below large EPC players and PSU project executors such as RVNL and Ircon, which often subcontract or package work to firms of its size, and above local labour contractors. It owns quarry and crusher assets in Odisha, which gives partial backward integration in aggregates and ballast. **Customer types and end-markets.** **Independent characterisation.** ARSS today is best seen as a post-insolvency shell rebuilding a regional EPC franchise. Three features drive the economics: - an operating business shrunk to about INR 15–80 Cr of quarterly revenue and still loss-making before exceptional items - an order book that is large relative to that revenue base, about 6x FY2025 revenue - a balance sheet whose equity depends mostly on arbitration receivables — the auditor disputes recognition of INR 708 Cr of them The new owner brings capital access and political and industrial networks in Odisha. The company does not yet have an audited track record of profitable execution under that owner.

Revenue$0.0B
Employees406
Market CapN/A
Founded2000
Bhubaneswar, India
Arrow

Arrow Greentech Limited

Premium
Information Technology

Arrow Greentech is a promoter-controlled, IP-led Indian specialty-materials micro-to-small-cap that operates two economically distinct engines under one roof. Its High-Tech Products segment — anti-counterfeit security films, threads, fibres, laminates and related intellectual-property income, largely sold to high-security paper mills and document/brand-protection customers, partly through a Netherlands subsidiary — generated roughly 82% of FY26 revenue and nearly all of the swing in earnings. Its Green Products segment, built on the Watersol® brand, makes the company India's largest manufacturer of cast polyvinyl-alcohol (PVA/PVOH) water-soluble films for agrochemical, detergent, construction-chemical, embroidery and healthcare packaging, plus bio-compostable films; it grew 52% in FY26 to INR 369 Mn. A third, still loss-making option is Avery Pharmaceuticals' mouth-dissolving strip platform. The business is effectively debt-free, carries ~INR 1,294 Mn of cash and investments, earns 30–40% EBITDA margins in strong quarters, and exhibits pronounced order-driven volatility. --- ### Company's own description In its FY26 Annual Report, management frames Arrow Greentech as an innovation-and-IP franchise — the Chairman's letter characterises innovation as the company's "identity" and describes patents as its deepest moat. The company describes itself as "India's largest manufacturer of water-soluble films, marketed under our Watersol® brand", with a widening basket of bio-compostable solutions, alongside a High-Tech and Security business that manufactures anti-counterfeit products, security elements and security films for document, brand and high-security applications [AR26]. Its investor materials enumerate five business lines: Water Soluble Films, Intellectual Property, Security Products, Avery Pharma, and Other (Watersol Capsules and BioPlast) [IP-Aug26]. Morningstar's business description (derived from filings) states that the operating segments are Green Products (Water Soluble Films, Bio-Compostable Products, other green products) and Hightech Products (Anti-Counterfeit Products, IPRs and other high-tech products), with the Hightech segment generating the majority of revenue [Morningstar]. ### Business model and revenue model | Revenue stream | Nature | Segment | Approx. FY26 weight | Comment | |---|---|---|---|---| | Security films, threads, fibres, laminates, brand-protection elements | Product sales (B2B, order/tender-driven) | High-Tech | Majority of ~INR 1,636 Mn | Lumpy; customer-order timing and procurement cycles drive quarterly swings [AR26] | | Patent out-licensing, know-how transfer, IP income | Licensing / royalty | High-Tech | Not separately disclosed | Company states it monetises key patents through out-licensing and production of patented products [IP-May26] | | Trading of raw materials for security products | Traded goods | High-Tech | Not separately disclosed | "Purchase of stock in trade" was INR 339 Mn in both FY25 and FY26, indicating a material traded component [IP-May26]; company states it deals in supply of various raw materials [IP-Aug26] | | Watersol® PVA water-soluble films | Product sales (B2B industrial) | Green | Majority of INR 369 Mn | Agrochemical, detergent unit-dose, embroidery, construction chemicals, laundry bags, mould release | | Bio-compostable films (BioPlast) and Watersol Capsules | Product sales | Green | Small | Single-use plastic substitution | | Mouth Dissolving Strips (MDS) — nutraceutical and Rx; CDMO | Product sales and contract development/manufacturing | Reported within group; Avery turnover INR 37.0 Mn in FY26 | ~2% | Loss-making subsidiary [AR26 AOC-1] | The mix is therefore predominantly product sales, with a licensing/IP overlay that is disclosed qualitatively but not quantified separately in the documents reviewed. There is no subscription revenue. ### Value-chain position Arrow sits in the middle of two specialty value chains. In water-soluble films it buys PVA resin and additives and performs batching, casting, slitting, curing, embossing, printing and packing [IP-Aug26] — converting a commodity polymer into a performance film sold to formulators and packagers (agrochemical and detergent companies, embroidery converters). In security products it supplies engineered security elements into high-security paper mills and document/brand-protection converters, making it a Tier-2 supplier upstream of security printers. It describes itself as "part of the niche group supplying such products globally", with "100% indigenous technologies" [IP-Aug26]. ### Customers and end-markets | End-market | Products | Customer type | Disclosure status | |---|---|---|---| | High-security paper (currency/cheque/passport-grade papers) | Security threads, multicolour fibres/planchettes, colour-shift films | Paper mills, security printers | Company says it is a "supplier to leading paper mills"; customer names not disclosed [IP-Aug26] | | Document and brand protection | Security laminates, self-destructive security packaging film, labels | Brand owners, converters, document issuers | Customers not disclosed | | Agrochemicals | Agrochemical packaging WSF | Agrochemical formulators (India, Brazil) | Q1 FY26 commentary noted increased exports to Brazil and negligible exports to the USA [ScanX] | | Home & laundry care | Detergent (AD) film, toilet-block film, Watersol Capsules | FMCG / private-label | Not disclosed | | Textiles | Embroidery backing film | Embroidery units | Not disclosed | | Construction chemicals, dyes & pigments | Packaging film | Chemical companies | Not disclosed | | Healthcare | Water-soluble laundry bags for contaminated linen; MDS | Hospitals; pharma/nutraceutical brand owners (CDMO) | Avery states a long-term contract signed with a "big MNC company for export markets" (counterparty undisclosed) [IP-May26] | ### Independent characterisation Arrow Greentech is best understood as a small security-materials company with a green-packaging hedge rather than the reverse. On FY26 numbers, High-Tech produced ~82% of revenue and, given the margin profile (the consolidated EBITDA margin moves from ~25% to ~41% as High-Tech revenue swings, per Q4 FY26 vs Q1 FY27 [IP-May26; IP-Aug26]), an even larger share of profit. The segment's customer concentration, procurement-driven order timing and the Netherlands subsidiary's outsized contribution (Advance Secure Products B.V. turnover INR 396 Mn and PAT INR 78 Mn in FY26 [AR26 AOC-1]) imply limited earnings visibility. The Green segment is structurally attractive (plastic-substitution tailwinds, India leadership) but at INR 369 Mn is too small to anchor valuation. The patent estate is real and growing, but direct licensing income is not quantified, so the "IP moat" thesis is evidenced more by grants than by disclosed monetisation.

Revenue$0.0B
Employees108
Market CapN/A
Founded1992
Mumbai, India
Aroot

Aroot Co., Ltd.

Premium
Information Technology

| Item | Detail | Source / date | |---|---|---| | Legal name | Aroot Co., Ltd. (주식회사 에이루트) | DART filings, 2026 | | Former names | J.Stephan Co., Ltd. (제이스테판; renamed to this in 2016). Before that, the company traded as Sewoo Tech (세우테크) per third-party databases. | Company history page; ZoomInfo/Datanyze/Investing.com | | Renamed to Aroot | 2020 | Company history page | | Founded / incorporated | 8 April 2002 | KIND Q1 2026 quarterly report | | Jurisdiction | Republic of Korea | DART | | Headquarters | 28-6 Gajangsaneopdong-ro, Osan-si, Gyeonggi-do, Republic of Korea; tel. +82-31-8077-5000 | Company website; DART rights-issue filing, 27 Aug 2026 | | Exchange / ticker | KOSDAQ (Korea Exchange): 096690 (Bloomberg 096690:KQ) | KRX | | Listing date | 1 December 2010 | DART summary via Digital Today, Nov 2025 | | ISIN | KR7096690003 | FinancialFilings; Eulerpool | | CUSIP | Not applicable (no US listing) | — | | FIGI | BBG001858SH9 (KQ line) | Eulerpool | | Fiscal year end | 31 December | Stockopedia/Refinitiv | | Fiscal period numbering | FY2026 is the 25th fiscal period (제25기) | KIND Q1 2026 report | | Employees (latest) | About 70–77 (parent level; third-party snapshots of 72, 77 and 70) | Simply Wall St; Morningstar AU | | Employee 3-year trend | Not publicly disclosed in accessible sources | — | | Auditor | Not publicly disclosed in accessible sources | — | | CEO | Seomun Dong-gun (서문동군), CEO since 2019 | Company history; DART filings 2026 | | Voting shares outstanding | 4,022,842 (as of 18 Sep 2026) | DART major shareholding report, 18 Sep 2026 | | Market capitalisation | About KRW 25bn (Stockopedia, Oct 2026, last price KRW 6,280). An implied KRW 28.1bn on 3 Sep 2026 is derived from the company's statement that its KRW 24.7bn proceeds equalled about 88% of market cap. | Stockopedia; Asia Economy, 4 Sep 2026 | | Enterprise value | KRW 82bn (Refinitiv). This predates the Sept 2026 cash receipt. | Stockopedia | | Websites | aroot.co.kr (corporate); miniprinter.com (SEWOO printers); arootmall.co.kr (Xiaomi distribution); xeonics.co.kr (UPS subsidiary) | Company website | The identification details supplied (KOSDAQ, 096690, miniprinter.com) map to the same listed entity. The company has changed its name twice but has kept its ticker and listing. The entity profiled is Aroot Co., Ltd. (주식회사 에이루트), KOSDAQ 096690, ISIN KR7096690003, corporate website aroot.co.kr. The printer-division website is miniprinter.com (SEWOO brand). Aroot is a sub-scale Korean industrial-printer manufacturer that has become a multi-business holding vehicle. Its legacy SEWOO business designs and builds POS receipt, mobile, label and RFID printers and printing mechanisms in Osan. That business sold about KRW 23.7bn of printers in FY2025, roughly three-quarters of them exported. Around this core, management has layered unrelated businesses. They include refurbished semiconductor lithography equipment (NSRC), waste-plastic recycling into solid refuse fuel (Aroot Eco), UPS power equipment (Xeonics), Xiaomi product distribution, and, since 2025–26, a Kazakhstan-licensed USD stablecoin and payments platform (FORTA/USDFT). Consolidated revenue was KRW 50.6bn in FY2025 against an operating loss of about KRW 5.6bn and a net loss of KRW 16.9bn attributable. The equity story rests on capital recycling, such as the KRW 24.7bn Woojin Gijeon exit in September 2026, and on new-business optionality rather than on demonstrated profitability. It is a speculative, control-concentrated micro-cap. --- ### Company's own description In its filings and corporate materials, Aroot calls itself the first Korean developer and seller of receipt-issuing printers, under the SEWOO brand. It says SEWOO printers reach more than 80 countries and about 200 client accounts, and that it is particularly competitive in mobile printers (company printer-division page). The Q1 2026 quarterly report describes a parent operating through these business lines: - printers; - distribution; - uninterruptible power supplies (via Xeonics); - semiconductors (via NSRC); - comprehensive waste recycling (via Aroot Eco); - finance; - other activities. The articles of incorporation also cover real-estate leasing, development and sales agency (KIND Q1 2026 report). ### Independent characterisation Aroot is best understood as a legacy hardware OEM attached to a shifting portfolio of diversification bets. These bets are financed largely with equity-linked instruments and asset recycling. 1. **Core cash-generating asset (Mini Print segment).** Thermal and dot-impact POS printers, mobile receipt/label printers, desktop label and RFID printers, and printing mechanisms. Sales go to POS system integrators, VAN/payment terminal makers, distributors and logistics users, domestically and in about 80 export countries. Revenue is product-based. There is a small aftermarket in accessories and consumables, but no meaningful recurring service revenue. 2. **Semiconductor equipment (NSRC).** A project-based business. NSRC buys used i-line/KrF lithography steppers and track tools, refurbishes and upgrades them, and sells them turnkey (installation and set-up) to small and mid-size fabs, mainly in China and Taiwan. It also sells technical services such as debugging and process testing. 3. **Recycling (Aroot Eco, 87.39%).** A gate-fee and product model. Aroot Eco takes industrial waste plastics, sorts and shreds them, and sells solid refuse fuel (SRF) to cement makers and power plants from a plant in Seosan, South Chungcheong. 4. **UPS / heavy electrical (Xeonics).** UPS solutions for industrial users. 5. **Distribution.** Official retail and e-commerce channel for Xiaomi products in Korea ("arootmall"). 6. **Digital finance (Aroot Kazakhstan Ltd., 100%).** Holds AFSA licences as a fiat stablecoin issuer and digital-asset custodian. The plan is to earn platform and settlement fees on the FORTA network and float income on USDFT reserves. At Q1 2026 it was pre-revenue in substance (finance segment revenue KRW 38M). **Value-chain position.** In printers, Aroot is a mid-tier branded OEM. It competes on price and customisation against larger Japanese, US and Chinese brands and does not control end-customer software ecosystems. In NSRC and Aroot Eco, it is an intermediary or processor with modest proprietary IP. **End-markets.** Retail and hospitality POS, including kitchen printers, where the company claims a high domestic share. Also transport and logistics (parcel labels, delivery receipts), parking and field services, public sector, healthcare and manufacturing. Outside printing: semiconductor fabs, power plants and cement kilns, industrial power users, consumer electronics retail, and cross-border B2B payments in Central Asia/CIS.

Revenue$0.0B
Employees70
Market CapN/A
Founded2002
Osan, South Korea
Arman

Arman Financial Services Limited

Premium
Information Technology

Arman Financial Services is a small-cap, Ahmedabad-headquartered rural and semi-urban lender. It runs a two-entity structure. Namra Finance, its wholly owned NBFC-MFI, carries the joint-liability-group and individual microfinance book of about INR 2,167 Cr (June 2026), roughly 74% of group AUM. The parent runs a diversified retail book of about INR 758 Cr: unsecured MSME loans, two-wheeler loans, loan against property (LAP) and a nascent solar-loan product. Group AUM reached a record INR 2,925 Cr at 30 June 2026. The group came through India's FY25–FY26 microfinance credit cycle with a peak-to-trough AUM contraction of about 17% and two loss-making quarters. It retained very high capitalisation: Namra CRAR was 38.8% and group equity about INR 979 Cr. Profitability is recovering sharply, with Q1 FY27 PAT of INR 45 Cr against a loss of INR 15 Cr a year earlier. The franchise has three defining traits: - a 30-year track record of cycle survival in Gujarat-anchored rural credit; - low leverage relative to MFI peers; - a promoter family that holds only about 22% of the equity alongside a 10% venture investor. Leadership is now in transition after the founder's death in August 2026. --- ### What the company does Arman is a pure-play retail lender to low-income, largely informal-sector borrowers in rural and semi-urban India. In its own exchange descriptions, it calls itself a Gujarat-based NBFC with interests in microfinance, micro-enterprise (MSME) loans, two-wheeler loans, solar loans and LAP [PR-Q4FY26; PR-Q1FY27]. The group was originally an asset-backed (vehicle) financier in Gujarat [ACUITE]. It moved its microfinance assets into Namra Finance when Namra received the first NBFC-MFI licence in February 2013. It started MSME lending at the parent in March 2017 [ACUITE Nov 2024]. ### Business model and revenue model | Revenue line (consolidated, INR Cr) | FY22 | FY23 | FY24 | FY25 | FY26 | |---|---|---|---|---|---| | Interest & dividend income | 220.6 | 386.7 | 593.1 | 618.9 | 577.2 | | Fees & commissions | 7.0 | 16.4 | 23.3 | 25.6 | 32.0 | | Gain on sale/assignment & investments | 7.5 | 20.8 | 45.1 | 85.6 | 36.7 | Arman earns almost all of its revenue as interest income on loans. Lending is spread-based: the company borrows from banks, NBFCs/FIs and NCD investors and lends at high-yield rates to underbanked households. Secondary revenue streams are: - gains on direct assignment (DA) of loan pools. These are recognised upfront under Ind-AS: INR 29.8 Cr in FY26 versus a higher level in FY25 [XBRL-FY26; AGG]. - fees and commissions: INR 32.0 Cr in FY26 [AGG]. - income from treasury investments. Source: [AGG] stockanalysis.com, consolidated, derived from company filings. The FY26 assignment gain of INR 29.78 Cr is confirmed in [XBRL-FY26]. There is no product, subscription or licensing revenue. The model is 100% lending/service income. ### Value-chain position Arman sits at the last-mile origination and servicing end of the rural credit chain: **Borrows wholesale:** At March 2026: 23.8% banks, 15.3% NBFCs/FIs, 38.0% NCDs, 20.1% DA [PR-Q4FY26]. **Originates through its own branch network:** It has about 400 branches across roughly 10–11 states (Screener profile citing company disclosures; earlier presentations cite 394 branches and about 7.6 lakh customers). **Recycles capital through securitisation and assignment:** Examples include the ICRA-rated PTCs backed by unsecured MSME receivables, with AFSL as originator and servicer [ICRA]. ### Customer types and end-markets | Product | Customer | End-market | |---|---|---| | JLG microfinance (Namra) | Women borrowers in rural households, organised into joint-liability groups; household income cap of INR 3 lakh under the RBI's 2022 framework [IP-2023/24] | Rural/semi-urban microfinance | | Individual microfinance loans (Namra) | Graduated MFI borrowers with repayment history; about 33% of the MFI book by June 2026 [CALL-Q1FY27 via FilingReader] | Rural micro-enterprise | | MSME loans (AFSL) | Informal micro-entrepreneurs (kirana, traders, small manufacturers), mostly unsecured small-ticket | Micro-enterprise credit | | Two-wheeler loans (AFSL) | First-time and thin-file buyers of motorcycles/scooters via dealer tie-ups (historically Hero, Honda, Bajaj, TVS, Suzuki, Yamaha, Royal Enfield) | Rural mobility finance | | LAP (AFSL) | Self-employed borrowers with property collateral | Secured small-business credit | | Solar loans (AFSL) | Rooftop and other solar adopters (pilot scale) | Green consumer finance | ### Independent characterisation The equity story is fundamentally a leveraged bet on Indian rural microfinance credit cycles. MFI is about 74% of AUM and carries most of the earnings volatility. The standalone MSME/2W/LAP book is the diversification lever and the steadier earnings contributor. In FY26 it delivered about INR 41 Cr of the group's INR 57 Cr PAT [PR-Q4FY26]. The company's distinctive feature versus listed MFI peers is conservatism of capital: - debt-to-equity of about 1.9x on balance sheet at FY26 [AGG]; - Namra CRAR of 41% at March 2026 [PR-Q4FY26]. This reflects large equity raises in FY23–FY24, just before the sector downturn. The trade-off is depressed ROE (6.3% in FY26) until leverage is redeployed.

RevenueN/A
Employees2,900
Market CapN/A
Founded1992
Ahmedabad, India
Arion

Arion banki hf.

Premium
Information Technology

Arion Bank is one of Iceland's three systemically important universal banks, alongside state-owned Landsbankinn and Íslandsbanki. It is the only one of the three that has been fully privately owned and widely held since its 2018 dual listing in Reykjavík and Stockholm. Domestic pension funds own most of the register. Arion's distinguishing strategic feature is its bancassurance-and-wealth model: it combines a full-service bank with Vörður, a fast-growing non-life and life insurer, and Stefnir, one of Iceland's largest fund managers, under a single loyalty proposition (Arion Rewards) delivered through an app voted Iceland's best for ten consecutive years. Corporate & Investment Banking is the profit engine; it has led the domestic equity capital market and holds the top share of Nasdaq Iceland equity trading. Group ROE was 14.9% in FY2025, against a target above 13%. The bank operates with a high CET1 ratio (~18%), a 50% payout policy plus buybacks, and an A3 Moody's rating. Its main constraint is a concentrated, volatile home market whose competition authority has twice blocked consolidation. --- ### Company's own description (FY2025 Consolidated Financial Statements) In its FY2025 financial statements, Arion describes itself as follows. It provides comprehensive financial services to individuals, corporates and investors in Iceland through three business segments: Retail Banking, Corporate & Investment Banking, and Markets. Two subsidiaries augment the offering. Stefnir is described as one of Iceland's largest fund managers. Vörður is described as the fastest-growing insurer in Iceland, offering non-life and life cover. The Bank also provides pension services and manages several pension funds. Management attributes three benefits to this diversity: a broad revenue base, a loan book balanced between retail and corporate, and a high share of mortgages. It positions the Group as a digital leader whose services are mostly accessible through the Arion app, and as a leading adviser to corporates and investors that has helped revive the Icelandic stock market. Its stated purpose is to help those who want to succeed in Iceland and the Arctic through smart and reliable financial solutions (CFS 2025, Board endorsement). ### Independent characterisation | Sector | Share of corporate loans | |---|---| | Real estate activities | 18.3% | | Construction | 15.7% | | Fishing industry | 15.6% | | Commerce and services | 12.6% | | Industry, energy and manufacturing | 10.2% | | Financial and insurance activities | 8.5% | | Accommodation and food service (tourism-linked) | 6.8% | | ICT | 5.9% | | Transportation | 2.6% | | Agriculture and forestry | 2.0% | | Public administration, health and social | 1.9% | Arion is a balance-sheet-led universal bank. Net interest income generated 67% of FY2025 operating income (ISK 52.5 bn of 78.4 bn). Net fee and commission income contributed 22% (ISK 17.1 bn). The insurance service result from Vörður contributed about 3% (ISK 2.1 bn). Net financial income was ISK 1.1 bn, and other operating income was ISK 5.5 bn, mostly a one-off gain on the Arnarland property development. Mapped onto the template's revenue-model categories: **Interest spread ("product"):** About two-thirds of revenue. Funded about 65% by customer deposits and 17% by covered bonds (Q4 2025 Factbook). **Fee-based services:** About 22%. Comprises asset management, capital markets and corporate finance, lending and guarantee fees, cards and payments, and collection services. **Insurance underwriting:** About 3% of operating income on a net basis. Gross insurance revenue was ISK 20.8 bn in FY2025. **Recurring/subscription-like income:** Partly embedded in asset-management fees on ISK 1,989 bn of assets under management and supervision, and in insurance premiums. **Licensing:** No licensing income. **Value-chain position.** Arion originates, funds, distributes and services credit (mortgages, corporate loans, consumer credit). It manufactures and distributes savings and investment products (Stefnir funds, pension products) and insurance (Vörður). It intermediates capital markets as broker, underwriter and adviser, and runs market-making in domestic securities and FX within Treasury. It is therefore vertically integrated across manufacturing and distribution in all three product families. The main exception is payments acquiring: the former subsidiary Valitor was sold to Rapyd and the sale completed in 2022. **Customer types.** - Individuals: about 48% of loans at YE2025 (ISK 640 bn), mainly residential mortgages of ISK 577 bn. - Corporates from SMEs to large caps: about 52% of loans (ISK 689 bn). - Institutional investors, pension funds and high-net-worth clients, served by Markets and Premia private banking. - International investors in Icelandic assets, served via Arctic Investments and the London-based Arion (Financial) Advisory Services Ltd. **End-markets.** Loans to corporates by sector at YE2025 (Q4 2025 Factbook): The Group's revenue is effectively all Icelandic, apart from a small London advisory subsidiary and syndicated international corporate exposures.

RevenueN/A
Employees901
Market CapN/A
Founded2008
Reykjavík, Iceland
Arihant

Arihant Institute Limited

Premium
Information Technology

Arihant Institute Limited is an Ahmedabad-based professional-examination coaching company. Since 1998 it has prepared students for the Chartered Accountancy (CA), Company Secretary (CS) and Cost & Management Accountancy (CMA/CWA) qualifications, and more recently ACCA and CPA, under the "Arihant Institute" brand. At its 2018 IPO on the BSE SME platform it presented itself as a regional leader. It cited more than 10,000 students taught, 205 national rank-holders in CA Intermediate and Final, 2,000+ qualified CAs and 175+ CSs, plus a Satellite Learning Programme and a franchise network intended to reach smaller towns. Since then the listed entity's operations have contracted sharply. Revenue fell from INR 1.75 crore in FY2019 to INR 0.03 crore in FY2021, and has stayed between INR 0.01 and 0.09 crore since. The company now functions as a near-dormant listed shell. It holds about INR 14.6 crore of mostly illiquid assets (aged receivables, long-standing advances and capitalised content), has minimal payroll, and its shares have not traded since December 2021. --- ### The company's own description The company's annual reports describe its purpose through a vision, mission and values statement that has barely changed since FY2018. The vision is to build a quality education institute that sets students' careers in accounts, law and finance on track. It promises thorough subject knowledge and support both before and after examinations. It also aims to extend the network beyond Gujarat to students in small towns through a Satellite Learning Programme (SLP). The mission is to rank among the top coaching institutes nationally. The original target date was 2020 (FY2018-19 and FY2019-20 ARs) and was later moved to 2025 (FY2020-21 AR) without commentary. The stated aim is to be India's most preferred coaching institute and to create a platform for entrance-exam preparation across streams. The four core values are ethics, integrity, student service and quality (FY2020-21 AR, p. 2). The MD&A (FY2020-21 AR, Annexure 4) says the company operates in a single segment, education. It describes current coaching for CA, CS, CWA, ACCA and CPA, and states an intention to expand into coaching for the Gujarat Public Service Commission (GPSC), UPSC and other competitive examinations. ### Business model and revenue model | Revenue stream | Description | Model type | Disclosure status | |---|---|---|---| | Classroom coaching | Fee-based batches for CA Foundation/CPT, Intermediate/IPCC and Final; CS and CMA levels; ACCA/CPA | Service (course fee per student per batch) | Not separately disclosed | | E-learning / recorded lectures | Recorded video content, capitalised as a "Recorded Content" asset of INR 2.20 crore gross | Digital product / licence | Not separately disclosed | | Franchisee centres / SLP | Satellite delivery to franchise partners. IndiaMART listing cites a network of 20 franchisees in various states | Franchise fee / revenue share | Not separately disclosed | | Study material | Stock-in-trade inventory of INR 0.054 crore (FY2021), unchanged from FY2020 | Product | Not separately disclosed | | Test series | Mock tests and evaluation from entry level to final (IPO profile) | Service | Not separately disclosed | The revenue line in the FY2020-21 financial statements (Schedule 14) is labelled "Sale of services – Coaching, E-learning & Franchisee centre". GuruFocus's description, derived from filings, lists revenue sources as education, e-learning, e-library, online study materials and others. The model has five parts: The faculty model is variable. "Cost of services – Professors" was INR 863,295 in FY2020 and INR 100,871 in FY2021 (Schedule 16). This shows faculty were paid per engagement rather than kept on payroll, which explains how cost could fall in step with the collapse in revenue. ### Value-chain position, customers and end-markets Arihant sits at the last-mile instruction layer of India's professional-qualification value chain. The examining bodies (ICAI, ICSI, ICMAI, ACCA) set syllabi and conduct exams. Arihant competes with private coaching providers to deliver preparation. Its customers are individual students. They are typically school-leavers entering CA Foundation and commerce graduates or articled assistants at Intermediate and Final level, concentrated in Ahmedabad and Gujarat. Secondary customers are franchise operators in smaller towns. The end-market is the Indian test-preparation and professional-coaching market for commerce qualifications. There is no institutional or B2B customer base, and no foreign-exchange earnings (FY2020-21 AR: NIL). ### Independent characterisation Arihant should not be analysed as an operating education business. The financial record shows a viable regional coaching franchise until about FY2019, with revenue of INR 1.7 to 1.8 crore and modest profits. After the IPO it deteriorated in three ways: 1. **Revenue collapse.** Revenue fell 67% in FY2020 and 95% in FY2021, then stayed below INR 0.1 crore. 2. **Capital lock-up.** IPO proceeds were redirected from the stated objects (training-centre expansion, studio and content) into debt repayment, creditor and statutory dues, and advances for technology and rental property. These advances then became stagnant balances. 3. **Compliance breakdown.** In FY2021 the secretarial auditor recorded 17 categories of non-compliance, and statutory dues were in arrears. The "Arihant Institute" coaching brand may continue to operate in some form in Ahmedabad (online directories still list it). There is, however, no evidence in the listed company's revenue that material coaching activity flows through it. The listed vehicle is best described as a dormant, asset-heavy-on-paper shell with a residual education licence and brand.

RevenueN/A
Employees1
Market CapN/A
Founded1998
Ahmedabad, India
Arihant

Arihant Foundations & Housing Limited

Premium
Information Technology

Arihant Foundations & Housing is a Chennai-centred, promoter-led mid-sized developer that has reinvented itself between FY2023 and FY2027 from a sub-scale, loss-making legacy builder into a fast-growing, capital-light urban developer. Its model rests on long-standing relationships with Chennai landowners: roughly 95% of projects are done through joint developments or JVs, which keeps land capital off the balance sheet. It is pursuing three premium niches — luxury residential in land-scarce central and IT-corridor micro-markets (Besant Nagar, Poes Garden, Perungudi, Velachery, Kilpauk), boutique Grade A offices for global capability centres (Guindy, Boat Club, Anna Salai), and organised senior living (with Ashiana Housing). A 2025 framework alliance with Prestige Estates has expanded its ongoing GDV to roughly ₹11,250 Cr. That is about 25x FY2026 revenue. The investment case is therefore the conversion of this pipeline into earnings, set against rising leverage, execution capacity limits and single-city concentration. --- ### What the company does Arihant develops and sells real estate. Its exchange descriptions cover the construction of residential and commercial complexes and IT parks. Company and data-provider profiles list a wider building range: villas, apartments, IT parks, hotels, shopping malls, multiplexes, developed plots and commercial buildings. In its financial statements the company reports a single reportable segment: real estate development and related activities, including construction (Morningstar profile, derived from annual-report segment note). In practice, the current business has four product verticals (company Q1 FY2027 factsheet, Valorem Advisors, 2026): 1. **Luxury residential and plotted development** — the largest share of the pipeline, at about 74% of ongoing GDV (₹8,788 Cr). 2. **Commercial / Grade A office** — about 13% of ongoing GDV (₹1,757 Cr) across seven ongoing projects, including Silhouette (Guindy) and Malar (Boat Club). 3. **Organised senior housing** — Swarang and Shubham, with Ashiana Housing, at about ₹706 Cr GDV. The factsheet labels this "13%", but ₹706 Cr is about 6% of ₹11,251 Cr. This internal inconsistency is flagged. 4. **Build-to-suit / development management for corporates** — for example, the corporate headquarters developed for Equitas Small Finance Bank on Anna Salai. ### Business and revenue model **Product sale (dominant):** Revenue comes mainly from selling residential units and office floor-plates. It is recognised under Ind AS 115, which in practice is mostly on completion and handover. Reported revenue therefore lags pre-sales by roughly 2–4 years. In FY2026, for example, pre-sales were ₹513.70 Cr against revenue from operations of ₹420.32 Cr. **Joint development (JD) model:** Landowners contribute land in exchange for a share of built-up area or revenue. Arihant contributes design, approvals, construction, marketing and brand. The company describes this as an asset-light model in which about 95% of projects are JVs/JDs (H1 FY2026 investor presentation). Its economic share of GDV is therefore much lower than headline GDV. As of September 2025, Arihant's share was ₹3,566 Cr of ₹6,336 Cr total GDV, or about 56%. **Platform JVs with national developers:** Canopy Living LLP (with Prestige Estates) acquires larger land parcels outright and develops them jointly. **Development for owner-occupiers:** Corporate build-to-suit projects such as Equitas SFB's headquarters produce bulk-sale revenue. A May 2025 company post headlined that Equitas had bought about 1.7 lakh sq ft from Arihant for about ₹300 Cr. **Recurring/annuity income:** Not material. The company does not disclose a leasing portfolio, and commercial assets are mostly built for sale. **Revenue-mix characterisation (independent):** about 95%+ product (property sale) revenue, with negligible service, subscription or licensing revenue. "Other income" (interest, JV-related income) is meaningful relative to profit: ₹15.0 Cr TTM in one 2025 data snapshot, and roughly ₹10 Cr in Q4 FY2026 alone. ### Value chain position Arihant is a vertically integrated developer for the stages that add the most value. It handles land aggregation and structuring (JD negotiation), design (it brands itself "design-first"), statutory approvals, construction management, sales and marketing, and handover. Civil construction is likely sub-contracted in part, but the split of in-house versus contracted construction is not publicly disclosed. The company does not own manufacturing or materials businesses. ### Customers and end-markets | Customer type | Description | Evidence | |---|---|---| | HNI / affluent end-users | Luxury apartments in Besant Nagar, Poes Garden, Kilpauk, Velachery, Perungudi | Miraya, Chirag, Kilpauk and Velachery projects | | IT / start-up professionals | High-rise premium housing near the OMR IT corridor | Perungudi MGR Salai project (35–40 floors planned per The Hindu, June 2025) | | Senior citizens (55+) | Organised senior living on ECR / Maraimalai Nagar | Swarang (Phase I: 99 of 134 homes sold, ₹110.58 Cr) | | Corporates / GCCs / BFSI | Grade A boutique offices, build-to-suit HQs | Equitas SFB HQ; Anna Salai, Boat Club and Guindy office projects | | Plot buyers | Plotted developments | Included in the residential/plotted GDV; project-level detail not disclosed | | Landowners (supply-side partners) | JD counterparties | About 95% of portfolio under JD/JV | ### Company's own description vs. independent characterisation *Company's description (paraphrased from FY2025–FY2027 investor materials and press releases):* a Chennai developer with a 40+ year legacy and 20–25 Mn sq ft delivered, a "design-first" approach, a capital-efficient JV model, and strong institutional relationships. It describes itself as a pioneer in organised senior housing and as pursuing a "5x growth" strategy. *Independent characterisation:* Arihant is a small-cap, high-growth, promoter-controlled developer with a single-city concentration. It is going through a scale-up driven by external equity (₹108.6 Cr preferential issue, 2024–26), a national partner (Prestige) and a premiumisation strategy. The quality of the delivery record is credible, with a long list of completed Chennai commercial and residential landmarks. The financial record before FY2023, however, was weak, with losses in FY2021–FY2022. Debt has risen to about 1.1x equity. The near-term earnings path is volatile, as the Q4 FY2026 PAT collapse to ₹4.29 Cr showed.

Revenue$0.0B
Employees75
Market CapN/A
Founded1980
Chennai, India
Argent

Argent Industrial Limited

Premium
Information Technology

Argent Industrial is a Durban-headquartered, JSE-listed small-cap industrial holding company. It has moved from a South African steel-trading and steel-beneficiation group into a diversified, increasingly offshore portfolio of niche branded manufacturers. Its roughly 25 operating units span South Africa, the United Kingdom, the United States and Canada. Their products range from security gates and louvre shutters to aviation refuelling vehicles, bunded fuel storage, rail-yard retarders, modular buildings and, since July 2026, steel drums and IBC reconditioning. The group's identity is capital allocation more than any single product. It buys small, profitable, often owner-managed niche businesses at single-digit earnings multiples (the Ramsden Group deal was priced at 5.5x profit after tax), funds them from internal cash, and returns surplus capital through steadily rising dividends and buybacks. In FY2026, offshore operations produced about 55% of revenue and about 73% of pre-tax profit, which makes the share a rand hedge. The balance sheet held net cash of about R500m before the Ramsden deal. --- ### Company's own description (AR2026) AR2026 calls Argent "largely a steel-based beneficiation group with a very diverse portfolio of businesses that include international brands". It reports 25 operating units across South Africa, the UK, the USA and Canada. The Directors' Report states that Argent "carries on the business of a holding company" and that "the group derives its income from the sale of manufactured products and trading of steel and steel-related products". Manufacturing is described as the group's largest activity. Management says vertical integration, self-sufficiency and diversification "protect the group from economic swings in any one segment of the market". The CEO's Review (AR2026) recasts the group as "an industrial engineering group with operations based in the UK, South Africa and North America, and exporting to markets worldwide". The stated strategic intent is "to grow profitability through streamlining the business by extracting maximum value from vertical integration and good management practice", with the group "always seeking new investments and investors". ### Business model and revenue model | Dimension | Characterisation | Basis | |---|---|---| | Holding structure | Decentralised holding company. The listed parent holds the investments; subsidiaries run with their own management ("participative management"). The FY2026 parent company had revenue (mainly dividends from subsidiaries) of R20.7m. | AR2026 statements of profit or loss | | Revenue type | Product sales recognised mostly at a point in time on delivery. A smaller share is recognised over time under fixed-price contracts, such as bespoke engineered equipment (refuellers, cranes, modular units). The group does not separately disclose service, maintenance, rental or spares revenue. | AR2026 accounting policy 1.9 | | Product vs service mix | Predominantly product. Service streams exist (Flofuel Support aviation servicing and spares; Pro Crane Services crane servicing; Fuel Proof and Fluid Transfer rental and sales bases; Drumcare IBC laundering and reconditioning from July 2026). They are not quantified. | Website; AR2026; Ramsden SENS | | Subscription / licensing | None disclosed | — | | Segments | Manufacturing (about 87% of FY2026 external revenue); Steel trading (about 13%); Properties (under 0.1% of external revenue, but a recurring contributor to PBT through intra-group rentals) | Segment reports; Smalltalkdaily | | Value-chain position | Mid-stream. The group converts steel, aluminium, timber and fibreglass into finished engineered goods, and trades and processes flat and long steel, stainless steel and aluminium (Phoenix Steel, Gammid, Koch's). Vertical integration runs from steel trading and service-centre cutting into in-group fabrication, plus owned properties and, in the Western Cape, aggregates and ready-mix concrete. | AR2026; website | | Customer types | B2B industrial: mining houses, airports and into-plane fuelling operators, construction contractors, plant-hire companies, Class I and short-line railroads, chemical and food processors (drum users), fabricators and engineering shops. B2C and trade: homeowners and installers buying security gates, shutters, braais and fireplaces, ladders and garden gates through retail and trade channels. | Website product descriptions | | End-markets | Residential and commercial security; residential home improvement; mining (SA underground); construction and civil infrastructure (Western Cape); aviation and airport fuelling; construction and plant fuel storage; materials handling and logistics; rail freight; industrial packaging (drums and IBCs); site welfare and modular accommodation; industrial doors | Website; AR2026 | ### Independent characterisation Argent is best understood as a South African-domiciled, UK-weighted serial acquirer of small industrial niche manufacturers, not as a steel company. Three features define it. First, capital allocation is the product. Since about 2018 management has redeployed cash from slower, capital-intensive South African operations into UK and North American businesses with higher margins and returns. Smalltalkdaily lists deals including Partington (2020, about £3.1m), American Shutters (2021, R56.9m), Mersey Container Services and Standmode (FY2025, £6.9m), Xpanda Canada (December 2024, consideration not disclosed) and the Ramsden Group (July 2026, £10.84m). Entry prices are low single-digit to mid-single-digit earnings multiples. Ramsden was priced at 5.5x profit after tax plus property at £2.49m. Second, the earnings mix has become a rand hedge. Rest-of-world operations generated 72.2% of FY2025 pre-tax profit (R264.9m of R366.7m) and about 73.1% in FY2026 (R300.2m of R410.5m, per Smalltalkdaily's reading of AR2026). The South African steel trading segment now loses money: FY2026 PBT was about –R10.5m, against +R5.8m in FY2025. Third, the balance sheet is cash-heavy and lowly geared. At 31 March 2026, cash was R629.2m against interest-bearing borrowings of R31.3m and lease liabilities of R97.3m. That cash equalled about 30% of the market capitalisation, which explains the CEO's comment that the share traded on "an ex-cash price-to-earnings multiple of 3.7 times" at year-end.

Revenue$0.2B
Employees1,216
Market CapN/A
Founded1993
Umhlanga, South Africa
ArfinIndia

Arfin India Limited

Premium
Information Technology

Arfin India is a Gujarat-based, promoter-controlled secondary-aluminium and alloys processor. It converts aluminium scrap and primary metal into intermediate products for three industrial end-markets: steelmaking, automotive and power transmission. For steel it supplies aluminium deoxidisers (deox notch bars, cubes and shots), calcium-silicon and other cored wires, and ferro-titanium. For automotive and foundry users it makes secondary aluminium alloy ingots. For power utilities and EPC contractors it supplies aluminium wire rod and bare overhead conductors (AAC/AAAC/ACSR, including AL-59), and it is expanding into covered and Extra High Voltage conductors. Capacity is about 71,000 tonnes a year. The business runs at low single-digit net margins, so earnings depend heavily on volume and working capital. It has three distinguishing features: a recycling-based, low-carbon feedstock model; a strategic partnership with Japan's JFE Shoji, which owns 5.81% and acts as exclusive distributor for deox and wire rod; and a new specialty-alloys subsidiary (ATSAL) being developed with Japanese technical support. Revenue in FY2026 was INR 618 crore and net profit INR 15.5 crore (consolidated), against a market value of roughly 100x trailing earnings. --- ### Company's own description The CMOTS-maintained company record, which reproduces the company's annual report language, says Arfin manufactures, trades and sells non-ferrous metal products from facilities at Chhatral, Dhanot and Vadaswami in Gujarat. It cites installed capacity of 71,000 metric tonnes per annum and lists the main products as aluminium wire rod, aluminium deox, cored wire, aluminium alloy ingots, ferro titanium, and conductors and cables. It describes customers in the steel, automobile and power sectors, in India and overseas. The FY2022 Annual Report ("enVISION more") describes the company as consistently investing in products and technologies for rapid growth and as delivering customised products. The 2014 Annual Report called Arfin one of India's key manufacturers of aluminium wire rod and deox and among India's best-known aluminium recycling plants. In its financial results Arfin reports a single operating segment: manufacturing and trading of ferrous and non-ferrous metals (NSE iXBRL Q2 FY2026; FY2026 audited results). ### Independent characterisation Arfin is best understood as a metal converter with a cost-plus, volume-driven model, not a commodity producer. It buys aluminium scrap (domestic and imported), primary ingot and ferro-alloy inputs. It melts, alloys, casts, rolls and draws them into intermediate products and sells at prices linked to LME/domestic aluminium benchmarks plus a conversion premium. Three economic features follow. 1. **Thin margins.** Gross margin is about 15–16% and EBITDA margin about 5–7%. Consolidated net margin was 1.5–2.5% across FY2022–FY2026 (Stockanalysis, consolidated). Small changes in conversion spread or interest cost move earnings sharply, which explains PAT up 69% in FY2026 on flat revenue. 2. **Working-capital intensity.** Inventory days were about 151 and the cash conversion cycle about 129 days in FY2026 (standalone ratios, Tapetide/Screener format). Growth is therefore funded largely by bank working-capital lines: cash credit of INR 82.7 crore plus overdraft rated by CRISIL. 3. **Order-backed visibility.** Since FY2023 the company has increasingly disclosed large, multi-month supply contracts: SABIC deox (INR 350 crore over four years), JFE Shoji (INR 180 crore and INR 300 crore), Diamond Power (INR 321 crore) and DGVCL (INR 85.59 crore). Revenue visibility is better than for a pure spot seller, but it is concentrated in a few counterparties. ### Revenue model mix | Revenue type | Estimated share | Comment | |---|---|---| | Product sales (manufactured) | Majority (exact % not publicly disclosed) | Deox, cored wire, alloy ingots, wire rod, conductors, ferro-titanium | | Trading of metals | Not separately disclosed | The reported segment explicitly includes "trading"; aggregators note the company "manufactures and trades" metals | | Services / subscription / licensing | Nil | None disclosed | | Export sales | Not publicly disclosed as a % | Exports confirmed (e.g., SABIC, Saudi Arabia, December 2022 order) | ### Value-chain position Arfin sits in the mid-stream of the aluminium value chain. Upstream it buys scrap and primary metal from recyclers, traders and primary producers (Hindalco, NALCO and Vedanta are the domestic primary suppliers of the industry). Downstream it supplies integrated steel mills, foundries and auto-component makers, and cable and conductor EPC contractors and distribution utilities. In conductors it is partly a supplier to larger cable and EPC companies (Diamond Power Infrastructure) and partly a direct supplier to state distribution utilities (Dakshin Gujarat Vij Company Ltd). ### Customer types and end-markets | End-market | Products | Named customers / channels (public) | |---|---|---| | Steel (deoxidation, ladle metallurgy, alloying) | Aluminium deox (notch bars, cubes, shots), cored wire, ferro-titanium | ArcelorMittal Nippon Steel India, JSW Steel, Tata Steel (Machinist.in); SABIC, Saudi Arabia (export); JFE Shoji India as exclusive distributor for deox and wire rod since 1 April 2024 | | Automotive / foundry | Aluminium alloy ingots (secondary alloys such as ADC12/LM-series) | Auto-component foundries (names not disclosed) | | Power transmission & distribution | Aluminium wire rod (EC grade/alloy), AAC/AAAC/ACSR conductors, MV covered conductors, EHV conductors (HTLS/ACSS/AL-59) under development | Diamond Power Infrastructure Ltd; Dakshin Gujarat Vij Company Ltd (Government of Gujarat) | | Specialty alloys (new) | Titanium and specialty alloys via ATSAL | MoU with Toyo Denka Kogyo, JFE Shoji Corporation and JFE Shoji India (June 2026) |

Revenue$0.1B
Employees225
Market Cap$0.2B
Founded1992
Gandhinagar, India
Arex

Arex Industries Limited

Premium
Information Technology

Arex Industries is a promoter-controlled Indian micro-cap that designs and weaves branded identification labels: woven labels in satin and taffeta, plus printed labels. Its customers are apparel, home-textile and footwear manufacturers. Founded in 1989 by Dinesh Bilgi and now run jointly with his sons Neel and Chirag, it operates two Gujarat plants. The first is a computerised weaving unit at Chhatral near Ahmedabad. The second is a captive-style unit at Anjar, Kutch, built beside Welspun's home-textile campus under a 10-year agreement in which Welspun committed to take at least 75% of that plant's capacity. CARE describes Arex as one of the larger organised domestic players in a niche, fragmented segment dominated by unorganised producers. Revenue has held at about INR 45–54 crore for five years, EBITDA margins sit in the mid-teens, and capacity utilisation runs at 40–60%. The investment case therefore depends on whether the company can lift utilisation, grow its small but fast-rising export book, and convert a planned move into packaging materials into growth. --- ### What the company does Arex makes garment and textile identification labels: the woven or printed tags sewn into apparel, bed linen, towels and footwear to carry the brand name, size, care instructions and other trim information. CARE (June 2025 and July 2026) describes the core product as woven labels of satin and taffeta quality in white or black warp-base, made in shapes, sizes and colours specified by each customer, alongside a line of printed labels. The company's legacy product page says it can supply about 414 million woven labels a year. The labels can be woven up to 500 mm wide in up to 12 colours, with coloured warp-bases available on custom orders. Edge options are ultrasonic cutting, hot-slit edges on broad looms, and soft edges on needle looms. Finishing options include end fold, centre fold, mitre fold, Manhattan fold, starching, special coatings, self-adhesive and thermo-adhesive backings, laser cutting, die cutting, filled-in labels and "comfort soft" finishes. ### Company's own description In BSE filings and its corporate profile, the company describes itself as a manufacturer and trader of woven and printed labels. It emphasises translating customer requirements into weaving patterns, a computerised plant using imported machinery, international quality standards, and reliable delivery against tight schedules. The FY2026 Integrated Annual Report's MD&A could not be accessed directly. Its key themes, as captured in secondary summaries, were softer domestic demand, sharply higher exports, rising employee costs, and an amendment to the Memorandum of Association adding packaging materials as a business object. ### Independent characterisation Arex is a business-to-business, made-to-order textile trim converter. Its economics follow from four features: 1. **Design-led, short-run manufacturing.** Every order starts with design work (CAD artwork translated into weave patterns), sampling and approval. This creates mild switching costs once a brand's label is approved. It also means a long order-to-cash cycle and heavy inventory, because Arex keeps stocks of many coloured yarns so it can respond to any brand's palette. CARE reported inventory periods of 68 days in FY25 and 87 days in FY26. 2. **Low share of customer wallet, low pricing power.** Labels are a tiny fraction of a garment's cost. Buyers are price-sensitive, and the unorganised sector caps price increases. CARE repeatedly notes that Arex has limited ability to pass on yarn price increases, which track cotton and crude oil. 3. **Capital intensity relative to revenue.** Weaving looms (airjet, rapier and needle) and finishing lines carry a large fixed asset base. At 40–60% utilisation, fixed-asset turnover was only about 0.47x in FY26 and 0.49x in FY25 (CARE). Depreciation of about INR 4.1–4.4 crore a year consumes more than half of EBITDA. 4. **Anchor-customer dependence.** The Anjar plant is effectively dedicated to Welspun under a minimum 75% offtake agreement. The top ten customers were 57% of operating income in FY25 and 60% in FY24 (CARE). ### Revenue model | Revenue type | Share | Comment | |---|---|---| | Manufactured product sales (woven labels) | Majority, exact split not publicly disclosed | Core business. Billed per piece or per batch on job-specific pricing. | | Manufactured product sales (printed labels) | Minority, not publicly disclosed | Installed capacity 15,000 million pick metres (CARE) | | Traded goods (labels / trims) | Not publicly disclosed | The company describes itself as "manufacturing & trading" | | Services / subscription / licensing | Nil | No recurring service or licensing revenue | | Power (wind) | Captive. Not separately disclosed as revenue. | Two windmills of 1.60 MW aggregate at Porbandar (CARE). Likely offsets grid power cost. | ### Value chain position Arex sits between yarn suppliers (synthetic polyester and cotton tape/yarn) and garment, home-textile and footwear manufacturers. Those manufacturers in turn serve domestic and global brands and retailers. Label specifications are often set by the brand owner, while the purchase order is placed by the garment or home-textile maker. Arex's relationship is therefore usually with the converter, such as Welspun or the Tirupur knitwear exporters, rather than with the end brand. ### Customer types and end-markets | End-market | Evidence | Demand character | |---|---|---| | Ready-made garments (domestic and export-oriented) | CARE: demand arises mainly from apparel / RMG | Cyclical. Follows domestic consumption and Indian apparel exports. | | Home textiles (towels, bed linen) | CARE: home textiles a key segment; Welspun is the anchor customer | Strongly linked to US retail demand. CARE noted the FY23–FY24 slowdown and recovery from Q4 FY24. | | Footwear | CARE: footwear is an additional end-market | Smaller share | | Export customers | Exports INR 2.97 crore in FY26 vs INR 0.75 crore in FY25 (+311%) | Nascent but growing |

Revenue$0.0B
Employees247
Market CapN/A
Founded1989
District Gandhinagar, India
Ardmore

Ardmore Shipping Corp.

Premium
Information Technology

Ardmore Shipping is a focused, mid-cap owner-operator of mid-size product and chemical tankers. It carries refined petroleum products, chemicals, vegetable oils and biofuels for oil majors, national oil companies, traders and chemical producers. The fleet is concentrated in fuel-efficient Eco-design and Eco-mod MR tankers (45,000–50,200 dwt) plus a niche of IMO2 product/chemical tankers (25,000–37,800 dwt). Most of the fleet is traded directly in the spot market, which gives shareholders high operating leverage to freight rates. Downside is cushioned by a cash breakeven of about $11,700/day ($10,800/day excluding capex). Since 2021 the company has cut leverage from roughly 1.1x debt/equity to near net cash. It distributes a variable dividend equal to two-thirds of adjusted earnings (raised from one-third in Q1 2026). Ardmore has consistently ranked at or near the top of Webber Research's governance scorecard for tanker companies. Under the CEO who took over in 2024, it is now renewing its fleet through a six-ship Handysize IMO2 newbuilding programme. --- ### The company's own description In its 2026 releases, Ardmore describes itself as a business that delivers energy, mobility and essential commodities by transporting refined products, chemicals and other liquid goods. It says it operates as a fully integrated shipping company, with core commercial, technical, operational and corporate functions carried out inside the public-company structure (16 June 2026 press release). The standard boilerplate used through early 2026 described a fleet of MR product and chemical tankers of 25,000–50,000 dwt. That fleet serves oil majors, national oil companies, oil and chemical traders and chemical companies through voyage charters, commercial pools and time charters (29 January 2026 Investor Day announcement). Management states the core strategy as building and running a modern, high-quality product and chemical tanker fleet, while using the integrated model to build long-term customer relationships and staying focused on cost, safety and performance (27 August 2026 release). ### Business model and revenue model Ardmore earns freight and charter-hire revenue. It has no product sales, subscriptions or licensing. Revenue comes in three forms: **Spot voyage charters:** These are the dominant source. Ardmore is paid per voyage and bears voyage costs (bunkers, port and canal charges). The 20-F counts voyage charters, trip charters and time charters of under three months as spot. At 6 March 2026, 21 of 26 vessels (including one chartered-in vessel) were trading spot directly. **Time charters out:** The charterer pays a fixed daily hire and bears voyage costs, while Ardmore bears vessel operating costs. At 6 March 2026, five vessels were on fixed-rate time charters: four MRs at an average of $22,650/day and one chemical tanker on a three-year charter at $19,250/day (Q4 2025 release). In early 2026 a 2020-built MR was fixed for one year at $26,000/day, and two 2014-built MRs began two-year time charters. **Commercial pools:** Pools were historically significant. The current strategy is direct spot trading through Ardmore's own commercial platform. Because spot revenue is recorded gross of voyage expenses, management focuses on the time-charter-equivalent (TCE) rate per day, which is revenue less voyage expenses divided by revenue days. TCE is the relevant measure of earning power. For example, Q2 2026 GAAP revenue was $116.2M, while aggregators reporting net (TCE-basis) revenue show about $86.4M for the same quarter. ### Position in the value chain Ardmore is a midstream logistics provider. It sits between refiners, chemical producers and traders, who own the cargo, and end markets. It is an independent owner rather than an industrial shipper, and it competes on vessel quality, vetting approvals (oil-major acceptance), fuel efficiency, cargo flexibility and commercial execution. ### Customers and end markets The customer base comprises oil majors, national oil companies, commodity traders, chemical producers and (historically) pool operators. Customer concentration figures are n/d in the sources reviewed. End markets are refined products (gasoline, diesel, jet and naphtha), easy-chemicals and IMO2 chemical cargoes, vegetable oils, and renewable or biofuel cargoes. The company reported that non-fossil-fuel cargoes made up 28% of total business in 2022 (2022 Annual Report summary). ### Independent characterization Ardmore is in practice a levered bet on mid-size clean-tanker spot rates, run with unusually conservative financial policy. Its distinguishing features are: 1. Low unit breakevens and very low balance-sheet leverage. 2. A fully variable payout policy, so shareholders capture cyclical upside directly. 3. A small but steady push into higher-specification IMO2 chemical-capable tonnage. This shows in the 2025 full-fleet MarineLine recoating, the 2025 chemical-tanker time charter, and the 2026 Handysize IMO2 newbuildings. Its main weakness is scale. With about 25 ships, Ardmore is a fraction of the size of Hafnia (over 120 vessels), Scorpio Tankers or TORM (about 92 vessels after its 2025 transactions). That limits commercial network effects and purchasing power.

RevenueN/A
Employees56
Market CapN/A
Founded2010
Bermuda
Arctic

Arctic Fish Holding AS

Premium
Information Technology

Arctic Fish is one of Iceland's three largest open-net-pen Atlantic salmon farmers. It is a vertically integrated, single-country producer whose entire value chain sits in the Westfjords. That chain runs from a recirculating-aquaculture (RAS) smolt facility at Norður-Botn in Tálknafjörður, through sea sites across five fjords licensed for 29,800 tonnes of maximum allowed biomass (MAB), to its own harvesting plant (Drimla) in Bolungarvík. Since December 2022 the company has been controlled by Mowi, the world's largest salmon farmer. Its second anchor shareholder is Síldarvinnslan, Iceland's largest pelagic and fishmeal group. Together the two hold close to 90% of the shares, leaving a thin free float. Arctic Fish is a build-up-phase grower. Harvest volume rose from 8.6 kt in 2022 to a record 14.8 kt in 2025, with guidance of 18.0 kt for 2026. Profitability, however, remains volatile and highly sensitive to salmon prices, biology and Icelandic fiscal policy, which in August 2026 prompted a freeze on new growth capital. --- ### Company's own description In its standard regulatory "in brief" boilerplate (used in every 2025–2026 release), Arctic Fish describes itself as a leading Icelandic salmon farmer with a sustainable value chain running from smolt to sales [S5][S20]. It cites four elements: - production capacity of 29,800 tonnes MAB; - licences covering 10 farming areas in 5 fjords, all in the Westfjords; - a state-of-the-art RAS hatching and smolt facility; - high-bearing-capacity sea sites with high-energy equipment, plus a newly completed harvesting facility sized to use the full licences and meet growth objectives. Earlier versions (Q1 2024) described the licences as 13 farming areas in 6 fjords. Of the 29,800 t MAB, 27,000 t is for fertile salmon and the remainder is for trout [S7]. ### Business model and revenue model | Revenue model element | Characterisation | |---|---| | Product vs. service | ~100% product (fresh HOG salmon); no service, subscription or licensing revenue | | Pricing | Predominantly spot-linked to European salmon reference prices, adjusted for size, quality and timing. The contract share is not publicly disclosed for Arctic Fish. Its peer Icelandic Salmon guided a ~10% contract share for FY2026 [S29] | | Sales channel | Historically sold "Free Carriage" through a sales agreement with a third party or group company [S9]. Under Mowi ownership the commercial set-up is integrated with Mowi's know-how; the specific sales-agency terms are not publicly disclosed | | Cost structure | Feed (sourced partly from Mowi Feed in Norway and Scotland [S6]), smolt, biological treatments (sea lice), wellboat logistics, harvesting, the Icelandic per-kg aquaculture fee, depreciation and interest | | Accounting | IFRS. Biological assets are carried at fair value, so reported EBIT swings with fair-value adjustments. Management therefore guides on "Operational EBIT", which excludes fair-value effects and non-recurring items | Arctic Fish is a pure-play commodity protein producer. Almost all revenue comes from selling harvested, head-on-gutted (HOG) Atlantic salmon. Small residual revenue lines (by-products, smolt or other income) are not separately disclosed in the material reviewed. ### Value-chain position Arctic Fish covers the upstream half of the salmon value chain: 1. **Freshwater/hatchery** – Arctic Smolt RAS facility at Norður-Botn, Tálknafjörður. After the expansion it can produce about 1,000 tonnes of smolt a year, or roughly 5 million 200 g smolt, enough to support around 25,000 t of harvest [S20]. It is supplemented by external smolt agreements [S7]. 2. **Seawater grow-out** – Arctic Sea Farm's net-pen sites in the Westfjords fjords (Patreksfjörður, Tálknafjörður, Arnarfjörður incl. Trostansfjörður, Dýrafjörður, Ísafjarðardjúp incl. Sandeyri; historically trout in Önundafjörður) [S19][S26][S28]. 3. **Primary processing** – the Drimla harvest plant in Bolungarvík, fully operational from July 2023. Before Drimla the company depended on external harvest capacity [S8][S19]. 4. **Sales** – exported fresh HOG salmon. Secondary processing (fillets, value-added) is not a material reported activity. The company is absent from feed manufacturing (it buys feed, partly from Mowi) and from consumer-products/value-added processing, where Mowi Consumer Products operates. ### Customer types and end markets Customers are seafood importers, distributors, processors and retail/food-service buyers in export markets. Arctic Fish does not publish a customer or market breakdown in the material reviewed. Icelandic fresh salmon is generally trucked and flown to continental Europe and North America. Peer commentary in 2026 noted that US tariffs were holding back that market for Icelandic salmon [S29]. Customer concentration is not publicly disclosed. ### Independent characterisation Arctic Fish is best understood as a sub-scale, licence-rich, capital-intensive grower. It sits inside a global major (Mowi) and is exposed to three dominant variables: the global salmon price, biology (lice, mortality, temperature) and Iceland's tax and regulatory regime. Its 2021–2025 history shows a repeated pattern. The volume ambition was credible on licence capacity but was repeatedly delayed by biological incidents (Q1 2022 mortality, the 2023 escape and lice crisis) and by infrastructure build-out (smolt plant expansion, a harvest plant commissioned in 2023). Unit profitability is weak when prices soften, because the company does not yet have Norwegian-scale cost absorption. Mowi and Síldarvinnslan have shown they will recapitalise the company (EUR 35 m in 2025). The thin free float and dominant shareholders, however, mean the equity trades as an illiquid option on Icelandic salmon farming rather than as a fully independent listed company.

Revenue$0.1B
Employees127
Market CapN/A
Founded2011
Westfjords, Iceland
Arcotech

Arcotech Limited

Premium
Information Technology

Arcotech Limited is a promoter-controlled Indian maker of non-ferrous semi-finished products: copper and copper-alloy strips, foils, sheets, coils and coin blanks. Its single plant is in Bawal, Haryana. In its peak years (FY2015–FY2018) it reported annual revenue of INR 650–765 Cr and operating margins of 10–14%. Two of its distinguishing positions were nickel-brass coil supply to the India Government Mint and a niche in micro-thin foils down to 0.035 mm. From FY2019 a working-capital and receivables crisis collapsed revenue to zero by FY2023. Its bank accounts became non-performing, its rating fell to default, and its shares were suspended in August 2021 for governance non-compliance. Net worth is now deeply negative (about –INR 382 Cr at March 2026), and borrowings are INR 557 Cr. In July 2026 the company disclosed a One Time Settlement (OTS) approved by all consortium lenders. If the OTS is funded and completed, it could allow a restart of operations. Arcotech is therefore best characterised as a distressed shell with a binary restructuring option. --- ### The company's own description In its regulatory and rating-agency disclosures, Arcotech says it is principally engaged in manufacturing non-ferrous semis. It reports a single operating segment. CARE Ratings (October 2026) describes it as making brass and copper foils, strips and sheets, including radiator brass foils and radiator copper foils, at its Bawal facility. Historical descriptions from the 2015–2016 exchange announcements, as summarised by MoneyWorks4Me and Business Standard, describe a broader range: **Alloys:** copper, brass, phosphor bronze, nickel silver, nickel brass, cupro-nickel, aluminium bronze, tin-bearing copper and silver-bearing copper. **Forms:** ingots, strips, sheets, plates, foils, bus bars and rods. **Downstream items:** coin blanks, key blanks, lugs, terminals and connectors. **Other:** some profiles mention aluminium products, including aluminium packaging. ### Business and revenue model (historical, as an operating company) | Dimension | Characterisation | |---|---| | Revenue model | Close to 100% product sales (manufactured metal semis). No disclosed service, subscription or licensing revenue. | | Pricing basis | Typical for the industry: metal cost (LME copper/zinc/nickel plus import duty) passed through, plus a conversion or "rolling" margin. The company does not disclose its exact pricing mechanism. | | Value-chain position | Midstream. It buys cathode, scrap and master alloys; casts, hot- and cold-rolls and slits strips and foils; and sells to OEM fabricators and government mints. | | Customer types | Government mint (India Government Mint, Mumbai, a unit of SPMCIL), automotive radiator makers, electrical and electronics component makers (terminals, connectors), lock/key makers, utensil and hardware fabricators, and traders. | | End markets | Coinage, auto thermal management (radiators), electrical distribution (bus bars), electronics, builders' hardware, and consumer metalware. | | Order structure | Mixed. Large tendered government orders (IGM 2014: INR 157 Cr; IGM 2015: INR 268.30 Cr, each with a 25% option) sat on top of a recurring industrial customer base. | ### Independent characterisation (current state) Today Arcotech has no operating business. - Revenue from operations has been nil in every quarter from at least Q1 FY2024 through Q1 FY2027, and nil for the full years FY2023–FY2026 (Screener; ScanX). - Expenses are now almost entirely finance cost (about INR 5.6 Cr per quarter) and depreciation (about INR 2.5 Cr per quarter). - The economic substance of the company is an industrial land-and-plant asset at Bawal (net fixed assets INR 117 Cr at March 2026) and a listed-company shell with about 29,000 shareholders. - Against these sit roughly INR 557 Cr of borrowings, INR 106 Cr of other liabilities, unprovided interest, and statutory dues in arrears. The July 2026 OTS turns the equity story into an option on two things: (a) the promoter raising enough funds to pay the OTS amount, and (b) restarting a copper-alloy rolling business in a market dominated by much larger and better-capitalised peers.

RevenueN/A
Employees4
Market CapN/A
Founded1981
District Rewari, India
Archit

Archit Organosys Limited

Premium
Information Technology

Archit Organosys Limited is a Gujarat-based, promoter-controlled micro-cap producer of chloroacetyl chemistry — principally monochloroacetic acid (MCA), sodium monochloroacetate (SMCA), chloroacetyl chloride (CAC) and trichloroacetyl chloride (TCAC) — supplying intermediates into agrochemicals (notably 2,4-D herbicide), pharmaceuticals (ibuprofen, diclofenac, aceclofenac), oilfield carboxymethyl cellulose, surfactants, cosmetics and pigments. It operates two manufacturing sites (Naroda GIDC, Ahmedabad and Narmad, Bhavnagar) and supplements manufacturing with trading of solvents and organic intermediates. With FY2026 revenue of INR 1,410 M (≈USD 16–17 M) and net income of INR 80.3 M, it is a sub-scale niche player in a global MCA industry dominated by Nouryon and CABB, and in India by the Nouryon–Atul joint venture Anaven. Its investment case rests on cyclical margin recovery, a debt-reduction track record, and a pending — recently withdrawn and to-be-restructured — related-party acquisition of Archit Life Science Limited that could transform its scale and capital structure. --- ### What the company does Archit Organosys manufactures and trades chemicals. Its core manufactured portfolio is built around the chlorination of acetic acid: chlorine reacts with acetic acid (with acetic anhydride as a catalyst source) to yield MCA, which is then either sold as acid, neutralised to SMCA, or carried further into acid chlorides such as CAC and TCAC. S&P's profile describes the company as providing MCA and SMCA for synthesis of agricultural chemicals, cosmetic surfactants, oil-drilling chemicals and plastic additives, plus organic chemicals, pigments and specialty derivatives, and adhesives and sealants sold under the "AOL" brand. Company-sourced descriptions (relayed through IIFL, Kotak and MarketScreener summaries) state that major customers include large Indian and international companies in agrochemicals, pharmaceuticals and cosmetics, and that the company sells across India as well as to the USA, Europe, Latin America, other Asian countries and South Africa. ### Company's own reporting description In its BSE results filings and annual reports the company identifies a single operating segment — "Manufacturing and Trading of Chemicals and Organics" — with two geographic segments, India and Rest of the World (MarketScreener; TradingView; S&P/SA geographic data). Screener's "About" text, drawn from the FY2023 annual report, characterises the company as engaged in manufacturing and trading of chemicals and organics. ### Revenue model | Revenue stream | Nature | Disclosure status | |---|---|---| | Manufactured goods (MCA, SMCA, CAC, TCAC, pigments, sealants) | Product sales, spot and contract, B2B | Split vs. trading not publicly disclosed in reviewed sources (Screener lists "Manufacturing share of revenue", "MCA share" and "CAC share" as extracted metrics behind a paywall) | | Traded goods (ethyl acetate, acetic anhydride, toluene and other organics/specialty chemicals) | Merchanting margin | ICRA (2017) confirms trading of these products; ScanX notes a sharp FY2026 shift from raw-material consumption toward purchases of stock-in-trade, implying a rising trading share | | Other operating revenue (export incentives, scrap) | Ancillary | S&P/SA "revenue as reported" (INR 1,438 M FY2026) exceeds operating revenue (INR 1,410 M) by other items | There is no subscription, licensing or service revenue. The model is a pure industrial B2B product/trading model. ### Value-chain position Archit sits in the mid-stream intermediates layer: it buys commodity feedstocks (acetic acid — which industry studies estimate at roughly 60–70% of MCA operating cost — chlorine, acetic anhydride, caustic soda) and sells functional intermediates to formulators and active-ingredient manufacturers. It is not backward-integrated into chlor-alkali (unlike the Atul–Nouryon Anaven JV, which uses Atul's own chlorine and hydrogen), which structurally exposes its margins to purchased-chlorine and acetic-acid pricing. It is also not forward-integrated into the agro-active or pharma API layers. ### Customer types and end-markets | End-market | Archit products used | Example downstream products | |---|---|---| | Agrochemicals | MCA, CAC | 2,4-D acid herbicide, other phenoxy herbicides, glyphosate-route intermediates | | Pharmaceuticals | MCA, CAC | Ibuprofen, diclofenac, aceclofenac intermediates | | Oilfield chemicals | SMCA/MCA | Carboxymethyl cellulose (CMC) for drilling fluids | | Surfactants & personal care | MCA/SMCA | Betaine-type surfactants, cosmetics, daily personal-use products | | Pigments | MCA derivatives | Organic pigments | | Plastic additives | MCA derivatives | Additives | | Construction/DIY | AOL adhesives & sealants | Sealant range | (Sources: IIFL/Kotak summaries; S&P profile; Screener key points.) ### Independent characterisation Archit is best understood as a sub-scale, single-chemistry commodity-to-semi-specialty producer whose earnings are driven by the spread between MCA/derivative realisations and acetic acid/chlorine costs, plus utilisation of a capacity base that was roughly tripled by the Bhavnagar project in FY2018. Profitability has been highly cyclical (operating margin of –4% in FY2019, 15% in FY2023, 6% in FY2024 and 12% in FY2026 per Screener). Exports, which reached ~26% of product revenue in FY2022, have retreated to ~13%, suggesting that international competitiveness weakened as Chinese supply normalised and as the large Anaven plant (32,000 tpa, commissioned 2020-21) reshaped the Indian market. The company's most important strategic question in late 2026 is not organic — it is whether the promoter-group transaction with Archit Life Science Limited proceeds, on what terms, and with what dilution.

Revenue$0.0B
Employees52
Market CapN/A
Founded1989
Ahmedabad, India
Archidply

Archidply Industries Limited

Premium
Information Technology

Archidply Industries Limited is a Daga family–promoted, small-cap Indian manufacturer and marketer of wood-based interior panels, operating from an industrial cluster at Rudrapur, Uttarakhand, close to the agro-forestry timber belt of northern India. The company sells plywood, block boards, flush doors, decorative veneers and high-pressure decorative laminates under the "Archidply" brand. Through its wholly owned subsidiary Archidpanel Industries Private Limited, it operates a new medium- and high-density fibreboard (MDF/HDF) plant at Sitarganj, Uttarakhand, commissioned in March 2024. Consolidated revenue reached INR 670.70 crore in FY2026. Archidply is a third-tier branded player well below the scale of Century Plyboards, Greenply and Greenpanel. Its differentiation rests on low-cost proximity to raw material, a long-standing dealer franchise, and an integrated plywood-laminate-MDF portfolio. However, its model relies heavily on traded goods (about 48% of standalone revenue in FY2026). The investment case now turns on whether the MDF subsidiary can reach sustained profitability and reduce group leverage. --- ### What the company does Archidply manufactures, sources and distributes wood-based and paper-based interior panel products for furniture, interiors, residential and commercial construction, and fit-out applications in India. Morningstar's company description, which mirrors the segment disclosures in the annual report, states that the company earns revenue principally from plywood, laminates, decorative veneers, MDF and flush doors. The broader range includes doors, densified laminates, clads, compacts and industrial laminates. The company reports three operating segments in its FY2026 audited results [RES-FY26]: 1. **Wood-based products — Plywood & Allied Products.** This covers plywood, block boards, flush doors and decorative veneers. 2. **Paper-based products — Laminates & Allied Products.** This covers decorative high-pressure laminates (HPL), densified laminates, clads, compacts and industrial laminates. 3. **Wood-based products — Medium Density Fibre Board.** At the consolidated level this is predominantly the output of subsidiary Archidpanel Industries Private Limited (AIPL). At the standalone level it reflects MDF traded or sold through the parent. ### Company's own description The company's FY2026 annual report (filed 3 Sep 2026) and its website describe the business in substance as follows (paraphrased). Archidply is a manufacturer of plywood and laminates operating ISO 9001 and ISO 14000-certified facilities. It maintains a national distribution footprint of about 20 sales offices, around 2,000 retailers and seven warehouses in India [SCR, citing company website]. A description syndicated through Groww adds that the company serves more than 2,000 business partners and runs manufacturing facilities in Uttarakhand making plywood, laminates and doors. It characterises the entry into MDF as a major strategic shift that responds to changing consumer preferences and environmental considerations. ### Business and revenue model | Dimension | Characterisation | Evidence | |---|---|---| | Product vs. service mix | ~100% physical product sales. No service, subscription or licensing revenue is disclosed. | [RES-FY26] segment reporting | | Manufactured vs. traded mix (standalone) | Traded goods were INR 243.71 crore, or 47.98% of standalone FY2026 revenue. The manufactured share rose to 52.02% in FY2026 from 47.58% in FY2025. | [INFOMERICS-26] | | Channel | Primarily distributors, dealers and retailers (B2B2C), plus direct sales to contractors, furniture makers and institutional buyers | Company website via [SCR]; [INFOMERICS-26] | | Customer concentration | The top five customers were 9.10% of FY2026 sales (FY2025: 9.00%) | [INFOMERICS-26] | | Supplier concentration | The top five suppliers were 23.06% of purchases. Imports were about 5% of total input requirements. | [INFOMERICS-26] | | Geographic concentration | No single Indian state exceeded 12.93% of sales. The top five states were 58.38%. | [INFOMERICS-26] | | Brand architecture | Umbrella brand "Archidply". | — | ### Value chain position Archidply sits in the mid-stream converter position of the Indian wood-panel value chain: **Upstream (inputs):** plantation and agro-forestry timber (purchased through relationships with local sawmills in Uttarakhand), face and core veneers (partly imported), decor paper and kraft paper for laminates, and resins and chemicals (urea, phenol, formaldehyde, melamine). Infomerics notes that timber cost per cubic metre fell 9.5% in FY2026, that core veneer and chemical costs were broadly stable, and that total raw material cost rose 6.0% to INR 124.68 crore (scope as reported by Infomerics). **Midstream (conversion):** plywood pressing, laminate pressing (Rudrapur), and MDF/HDF continuous pressing (Sitarganj, through AIPL). **Downstream (distribution):** dealer and retailer networks, with brand-led pull from carpenters, interior designers and architects. Archidply also buys finished goods from third parties and resells them under its brand. This is the traded-goods component, which carries thinner margins. ### Customer types and end-markets | Customer type | End-market | Products consumed | |---|---|---| | Dealers / distributors / retailers | Residential interiors (new build and renovation) | Plywood, block board, laminates, veneers, doors | | Carpenters and contractors (influencer channel) | Modular and on-site furniture | Plywood, MDF, laminates | | Furniture OEMs and modular kitchen makers | Ready-to-assemble and modular furniture | MDF/HDF, pre-laminated boards, laminates | | Commercial and institutional projects | Offices, hospitality, retail fit-outs | Laminates (compacts, clads), doors, plywood | | Industrial users | Industrial applications | Industrial laminates | ### Independent characterisation Archidply is best understood as a regional-to-national, family-controlled branded panel company. Its manufacturing scale is modest, and nearly half its standalone sales come from trading. The FY2024 MDF investment changed the group in three ways: it added a capital-intensive manufacturing asset, roughly doubled the fixed-asset base (INR 64 crore at March 2023 to INR 148 crore at March 2024 [SCR]), and pushed group debt from INR 83 crore to INR 196 crore by March 2025. The MDF venture is now the swing factor in group economics. It supplied 25% of consolidated income and 51% of consolidated debt in FY2026 [INFOMERICS-26]. It turned EBITDA-positive in FY2026 but was still loss-making at the PAT level. The parent's legacy plywood business generates steady but thin returns: its standalone EBITDA margin was 5.57% in FY2026 [INFOMERICS-26], compared with segment margins of roughly 15% at the industry leader Century Plyboards.

Revenue$0.1B
Employees397
Market CapN/A
Founded1995
Rudrapur, India
Archidply

Archidply Decor Limited

Premium
Information Technology

Archidply Décor is a micro-cap, single-plant maker and trader of wood-based interior products. It was carved out of Archidply Industries Ltd in a court-approved demerger of the Chintamani (Karnataka) undertaking, with an appointed date of 1 April 2018, and listed in October 2020. Its portfolio covers decorative veneers, Gurjan and hardwood plywood and blockboard, pre-laminated particle board and MDF, flush and decorative doors, and premium surfaces sold under the Pureply, Bon Vivant and Archidply Décor Club brands. Customers are dealers, architects, interior designers and residential and hospitality projects, concentrated in South India. With FY26 revenue of ₹46.33 Cr, an EBITDA margin of about 4%, near-zero net profit and a cash-conversion cycle above 400 days, ADL is a sub-scale participant in an industry led by much larger organised players. Its investment case rests mainly on asset backing: the stock trades at about 0.77x book. The Daga promoter family controls about 73% of the equity. --- ### What the company does ADL manufactures and trades wood-based panel and surface products for interiors. In its own description, the company's activity is manufacturing and trading of "Wood Based Products" in the domestic market. It sources raw material and traded goods locally and also imports them. The product lines it reports are Decorative Laminates, Decorative Veneers, Plywood and Blockboard, and Pre-laminated Particle Board (FY25 Annual Report, as extracted by Screener; FY26 AR MD&A). The company states it has operated in decorative veneers and Gurjan plywood for over four decades, a heritage carried over from Archidply Industries, and that it serves residential and hospitality projects. For Ind AS 108 purposes the business is a single operating segment, "Wood based products." The company reaffirmed this in a February 2023 clarification to NSE and again in the FY26 MD&A. ### Business and revenue model | Dimension | Characterisation | Evidence | |---|---|---| | Product vs. service | Almost 100% physical product sales; no service, subscription or licensing revenue is disclosed | FY26 AR P&L | | Make vs. trade | Hybrid. In FY26, cost of materials consumed was ₹1,801.01 lakh and purchases of stock-in-trade were ₹1,476.42 lakh, so traded goods made up about 45% of total material-plus-purchase cost | FY26 AR MD&A | | Channel | Dealer and distributor network, a company showroom in central Bengaluru, a direct-to-consumer web shop, and architect/designer specification | Company website; FY26 AR outlook | | Geography | Domestic only. FY26 export earnings were nil; foreign-exchange outgo of ₹248.76 lakh relates to imported raw materials, stores, capital goods, travel and promotion | FY26 AR Annexure A | | Value-chain position | Mid-stream converter. It buys veneer logs, face veneers, timber, resin and boards, then peels, slices, presses, laminates and finishes. It also trades finished panels, including MDF, sourced from third parties and a related party (The Mysore Chipboards Ltd) | FY26 AR; AOC-2 | ### Customer types and end-markets The end-markets are residential new-build and renovation (wardrobes, modular kitchens, wall panelling and doors), hospitality interiors, and commercial/office fit-outs. The FY26 MD&A identifies the demand drivers as residential construction, real-estate development, renovation, commercial spaces and the shift toward organised furniture and interiors. Customer concentration is not disclosed. The key audit matter on revenue recognition (volume discounts, rebates, scheme allowances) indicates a dealer-incentive-driven trade channel. ### Independent characterisation ADL is best understood as a regional premium-veneer and decorative-panel house attached to a small plywood and pre-lam operation. It runs one plant, has 50 employees and depends heavily on its promoter group for brand, sourcing and financing support (Archidply Industries provides a corporate guarantee). Its economics are those of a distributor-manufacturer: **Moderate gross margins:** of about 27–31% over FY22–FY26. **Thin operating margins:** of 4–7% EBITDA. - **Heavy inventory**, with inventory days of 220–456 over FY19–FY26. This is structural for a veneer business that must stock a wide range of species and lots. **Interest costs that absorb nearly all operating profit:** EBITDA-to-interest was 1.1x in FY26. The business has not shown operating leverage. Revenue in FY26 (₹46.33 Cr) was below FY23 (₹50.50 Cr) and roughly flat on FY2019 (₹54.28 Cr, Screener basis).

Revenue$0.0B
Employees50
Market CapN/A
Founded2017
Chikkaballapur, India
ARB

ARB Holdings Limited

Premium
Information Technology

ARB Holdings is a family-founded South African distribution group with two operating businesses. The first is ARB Electrical Wholesalers, which Sabvest describes as one of Southern Africa's largest distributors of power and instrumentation cable, overhead-line equipment and conductors, and low-voltage and solar products. The second is the Eurolux/Radiant lighting business, which sells lamps, luminaires, fans and accessories to retailers and the electrical wholesale channel. A corporate division owns the group's distribution properties and a small ERP software house. The business model is working-capital intensive and asset-light in trading terms: it holds stock, gives credit and fills project and replenishment orders from a national branch network anchored by a large Midrand distribution centre. Earnings track South African infrastructure, mining and construction activity, copper prices, the rand and household discretionary spending. Since its 2022 take-private by Masimong and Sabvest alongside the Burke family, ARB has run as a debt-free, cash-generative private company. It has added cable-feeder/fibre connectivity and full ownership of its lighting arm. --- ### The company's own description (paraphrased from FY2019–FY2021 results) ARB described itself as an investment and property holding company that owns trading and distribution businesses. Its major holdings were: **74% of ARB Electrical Wholesalers (Pty) Ltd:** This is a B-BBEE Level 2 company running a national branch network: 21 branches at June 2020. The FY2019 report said 26 branches and the FY2020 report gave the FY2019 comparative as 22; the two figures conflict. **60% of Eurolux (Pty) Ltd:** (later 100%), which imports and distributes light fittings, lamps and related accessories. The group reported three segments: **Electrical:** distribution of power and instrumentation cable, overhead-line (OHL) equipment and low-voltage products. **Lighting:** distribution of halogen, fluorescent and LED lamps, light fittings and electrical accessories. **Corporate:** property investment, specialist IT services (Xact ERP Solutions), strategic and technical consulting, and head-office companies. ### Current description (Sabvest, FY2025 annual results, March 2026) Sabvest describes ARB as a distributor of electrical, lighting and related products to the mining, industrial, construction, parastatal, retail and domestic markets in Southern Africa. It notes three things: - ARB Electrical Wholesalers sells across three main categories: power and instrumentation cable; overhead-line equipment and conductors; and general low-voltage and solar products. - Eurolux and Radiant are leading distributors of energy-saving, LED, halogen and fluorescent lamps, light fittings, electrical accessories, cut cable and ancillary products such as fans and lighting components. - ARB holds 67% of Cable Feeder Systems (Pty) Ltd, with options to go to 100%. Cable Feeder Systems provides end-to-end copper and fibre connectivity solutions in South Africa. ### Business and revenue model **Revenue model:** almost entirely product distribution. There is no material subscription or licensing revenue. Small service and rental elements are Xact ERP software and services, and property rentals. Property rentals are mostly charged to group companies and eliminated on consolidation: Corporate segment external sales were only R9.0 m in FY2021. **Value-chain position:** a middle-tier distributor and importer between global and local manufacturers and end-users. Suppliers include local cable makers, Chinese OHL and low-voltage makers, Rockwell Automation (via CraigCor), Sungrow and SolarEdge (solar), and historically Nexans Olex, CHINT, ACCC and Fushi Copperweld. Customers include contractors, mines, industry, utilities and municipalities, retailers, other wholesalers and cash customers. **Value added:** stock depth (an advantage during the 2020–2021 supply shortages), credit extension (partly insured), national logistics, project supply, exclusive distribution rights, and compliance capability (Eskom LAP-listed OHL products; NRCS letters of authority for lighting). **Working-capital model:** management targeted working capital at 20–25% of revenue and reported being inside that range in FY2021. ### Customer mix | Customer type | FY2019 | FY2020 | FY2021 | |---|---|---|---| | Mining and industry (R m) | 1011.6 | 928.4 | 1202.2 | | Cash customers (R m) | 490.9 | 433.9 | 488.8 | | Wholesale (R m) | 413.2 | 278.6 | 420.6 | | Retail (R m) | 330.0 | 325.1 | 407.7 | | Exports (R m) | 172.6 | 145.9 | 196.5 | | Other (R m) | 287.8 | 241.2 | 207.2 | | Total revenue (R m) | 2706.2 | 2353.0 | 2922.9 | ### End-markets - Mining and heavy industry: the largest group at 41% of FY2021 revenue. - Construction and contractors, including data-centre projects (cited in FY2021). - Eskom, municipalities and electrification programmes, through overhead-line products. - DIY and home-improvement retail, through Eurolux. - Residential and commercial solar, from about 2022–2023. - Exports, mainly to sub-Saharan Africa: 6.7% of FY2021 revenue. ### Independent characterisation ARB is a cyclical, South Africa-concentrated, working-capital-heavy distributor with three structural traits: - Earnings are highly geared to volume and to the rand price of copper. FY2021 operating profit doubled on a 24% revenue rise. - Reported earnings were historically distorted by put-option revaluations on Eurolux and CraigCor minorities and by impairments. HEPS is therefore the better guide. - Since 2022, ownership has been patient and private. The group has used its cash to buy out the Eurolux minorities and to diversify into connectivity through Cable Feeder Systems. It carries no net debt: Sabvest calls it debt-free and cash-generative (Financial Mail, Sept 2025; Sabvest FY2025).

Revenue$0.2B
Employees526
Market CapN/A
Founded1980
Durban, South Africa
Aptech

Aptech Limited

Premium
Information Technology

Aptech Limited is one of India's oldest non-formal and vocational education franchisors. It was founded in 1986 and has been controlled since the mid-2000s by the Jhunjhunwala family, alongside co-investors. The company runs an asset-light, franchise-led retail training network of roughly 750 centres. Its brands are Arena Animation, MAAC, Lakmé Academy powered by Aptech, Aptech Computer Education, Aptech Aviation Academy, Aptech International Preschool, Avalon, Aptech Learning, The Virtual Production Academy and ProAlley. The network covers animation/VFX/gaming, beauty and wellness, IT, aviation/hospitality and preschool. The company also has a fast-growing Institutional (B2B/B2G) business. It conducts computer-based examinations (CBT), OMR tests and skill-training programmes for state and central government bodies, as well as corporate training. In FY2026 that business tripled its revenue to INR 114.2 crore, about 23% of the group. Aptech is debt-light and pays out most of its earnings as dividends. However, its margins have compressed sharply since FY2023. The investment debate now centres on three things: - whether retail can be revived; - the quality and lumpiness of government contract revenue; - a governance and leadership transition that has left the company without a CEO since January 2025. --- ### Company's own description The Q4 FY2026 investor presentation (25 May 2026) and the boilerplate in each Regulation 30 work-order filing describe Aptech in broadly consistent terms: - It is a global learning-solutions company with more than three decades in education, training and assessment. - It operates through two segments, Global Retail (individual training) and Institutional Business. - Retail offers career and professional training through multiple brands. These include Arena Animation, Maya Academy of Advanced Cinematics/Creativity (MAAC), Lakmé Academy powered by Aptech, Avalon Academy, Aptech Learning, The Virtual Production Academy, ProAlley, Aptech Aviation Academy and Aptech International Preschool. - Institutional covers training and assessment solutions for corporates and institutions, under the labels Aptech Training Solutions and Aptech Assessment & Testing Solutions. The presentation frames the revenue model in two parts: - Retail supplies scalable, annuity-like growth from enrolment-driven, repeat intakes. - Institutional supplies diversification and downside protection through project- and contract-based assessment and training revenue. ### Business model and revenue model | Revenue stream | Segment | Nature | Model characteristics | |---|---|---|---| | Franchise start-up fees | Retail | One-time | Paid by new centre partners when they join a brand network | | Franchise renewal fees | Retail | Recurring (periodic) | Paid on renewal of franchise agreements | | Course fees / revenue share | Retail | Recurring, enrolment-driven | Student fees are collected by franchisees or company centres, and Aptech recognises its share. Historically Aptech has received roughly 20% of revenue generated at the centre level in some brands (Outlook Business, historical). | | Courseware, content and certification | Retail | Recurring | Curriculum, learning material and examinations for network students | | Company-owned/managed centre revenue | Retail | Recurring | Direct training revenue where centres are operated by the company or its subsidiaries | | Online training (ProAlley) | Retail | Transactional/subscription | Online and hybrid upskilling programmes | | Computer-based examination services | Institutional | Project/contract | End-to-end CBT for state and central government recruitment and eligibility exams, run under RFP and master service agreement (MSA) terms | | OMR-based testing | Institutional | Project/contract | Example: an INR 6.0 crore OMR test order in May 2026 | | Government skill-development training | Institutional | Project/contract | Examples: INR 4.79 crore (Jul 2026) and INR 5.66 crore (Sep 2026) training work orders | | Corporate training | Institutional | Project/contract | Training solutions for enterprises | **Mix (FY2026):** - Retail (franchise and service-based training): about 77% of revenue from operations (INR 389.2 crore). - Institutional (services and contracts): about 23% (INR 114.2 crore). Licensing in the classical IP sense is embedded in the franchise model. Aptech licenses its brands and curricula to franchisees. There is no material product-sales line; inventory was only INR 4.3 million at FY2026 year-end (StockAnalysis). ### Value-chain position Aptech sits in the curriculum-design, brand-licensing and certification layer of the vocational education value chain: **Retail:** Most physical delivery (real estate, faculty, local marketing) is pushed to franchise partners. Aptech keeps control of brand, content, academic standards, placement networks and certification. **Institutional:** Aptech acts as an exam-services integrator. It handles test-centre networks, proctoring, software platforms and logistics for government bodies, which publish an audited list of exam cities and centres and enforce service-level agreements (SLAs) under MSA terms. ### Customer types and end-markets | Customer type | Segment | End-market | |---|---|---| | School leavers, graduates and career switchers (B2C) | Retail | Animation, VFX, gaming and virtual production (Arena, MAAC, TVPA) | | Beauty and wellness aspirants (B2C) | Retail | Beauty, hair, make-up and wellness (Lakmé Academy powered by Aptech) | | IT learners (B2C) | Retail | Software, hardware and networking (Aptech Computer Education, Aptech Learning) | | Aviation, hospitality and retail job seekers (B2C) | Retail | Cabin crew, ground staff, hospitality, luxury retail (Aptech Aviation Academy) | | Parents of preschool children (B2C) | Retail | Early-childhood education (Aptech International Preschool) | | English language learners | Retail (historical) | English training (formerly English Express, acquired 2009) | | State government bodies and autonomous bodies | Institutional | Recruitment/eligibility exams (CBT, OMR) and skill-development training | | Central government bodies | Institutional | CBT (e.g., an INR 1.94 crore order in Jul 2025) | | Corporates and educational institutions | Institutional | Corporate training and assessment | | Overseas franchise partners | Retail | International network; 181 centres outside India per the Q1 FY27 disclosure, including Nigeria | ### Independent characterisation Aptech is best understood as two different businesses inside one company. **The franchise brand-licensing business** is mature and low-capital, but cyclical. Its growth now depends on the animation/VFX hiring cycle, discretionary household spending on non-degree courses, and competition from online and ed-tech alternatives. Retail revenue fell from about INR 424.9 crore in FY2025 to INR 389.2 crore in FY2026 (−8.4%). Retail segment profit fell 9% year on year in Q1 FY2027, even as revenue grew about 5%. Together these point to a franchise network under pricing and volume pressure. **The government-assessment contractor** is growing quickly but lumpily. Revenue tripled in FY2026, and the business is now the incremental profit engine: Q1 FY2027 segment result was INR 3.00 crore, against INR 0.91 crore a year earlier. It carries reputational and regulatory risk from India's exam-integrity environment, including the Public Examinations (Prevention of Unfair Means) Act, 2024, and an ongoing investigative matter linked to 2022 testing activity. The consolidated result is a company with: - high gross margins (more than 80% on the aggregator definition); - low and compressed operating margins (about 4–5% in FY2025–FY2026, down from about 15% in FY2022–FY2023); - earnings that lean heavily on treasury and other income.

Revenue$0.1B
Employees611
Market CapN/A
Founded1986
Mumbai, India
Aptamer

Aptamer Sciences Inc.

Premium
Information Technology

CHOOLIP & SCIENCES is a micro-cap KOSDAQ company in transition. It was founded in 2011 as Aptamer Sciences, a POSTECH spin-off built around proprietary SELEX aptamer discovery. For most of its history it was a pre-revenue platform biotech: it commercialized one approved diagnostic (the AptoDetect™-Lung blood test, MFDS Class 3, 2017), and in 2024 it took its lead therapeutic, AST-201, a GPC3-targeted aptamer-drug conjugate (ApDC™), into a Phase 1 trial. KOSDAQ listing-maintenance thresholds for revenue and pre-tax losses forced a sequence of defensive measures. These included absorbing a bioanalytical CRO (ISS) in 2024, raising equity repeatedly, and handing control to Altcast in 2025. In 2026, new management bought a US premium pet-treat brand (Choolip Inc., US$11.4M) and renamed the company after it. Today the company combines an early-clinical oncology platform (AST-201 with an MSD Keytruda supply agreement; Trop2-ApDC preclinical) with CRO, oligo-synthesis and consumer pet-nutrition revenue lines. Value depends heavily on capital-markets access. --- ### Company's own description In its corporate materials, the company describes itself as an R&D-driven biotech commercializing aptamer technology platforms for innovative therapeutic and diagnostic products. It positions itself as able to generate high-affinity, high-specificity aptamers, optimize them, and develop new therapeutic and diagnostic modalities from them (Scientist.com / Informa Asia TIDES exhibitor profile). Its 2024 English press release describes it as a KOSDAQ-listed leader in the aptamer field with an integrated platform, branded ApDC™ (Aptamer Drug Conjugate), focused on oncology pipelines (PR Newswire, 25 March 2024). Filing-aggregator summaries of the FY2025 annual report describe a clinical-stage biopharmaceutical company whose development pipeline also includes Aptamer Radioligand Conjugates (ApRC) and Aptamer Immune Stimulator Conjugates (ApIS) (FinancialFilings.com). When the name changed, the company said in public statements that it would keep both the drug-development and CRO businesses, and would use distribution of healthcare and lifestyle products as an additional revenue base (Dealsite, 6 July 2026). ### Independent characterization The company is best described as a hybrid micro-cap with four economically distinct activities: 1. **Aptamer therapeutics (core value driver, pre-revenue).** The ApDC platform links a target-specific DNA/RNA aptamer to a cytotoxic or functional payload. The lead asset, AST-201, embeds gemcitabine within the sequence of a GPC3-binding aptamer. A Trop2-targeted ApDC (AST-203a) and an ApDC immuno-oncology candidate (AST-202) follow. The monetization model is out-licensing (technology transfer) and co-development; no license deal on a therapeutic asset has been publicly announced to date. 2. **Diagnostics.** AptoDetect™-Lung is a blood-based multi-protein (7-marker) aptamer assay that produces a lung-cancer risk score. It is sold in Korea through non-reimbursed (self-pay) hospital channels and, from 2023, through health-screening providers. Revenue has historically been very small. 3. **Services (CRO / bioanalysis / oligo synthesis / custom aptamer discovery / reagent distribution).** This line came mostly from the 2024 absorption of International Scientific Standard Inc. (ISS), a bioanalytical CRO, plus oligonucleotide synthesis and custom aptamer discovery contracts (e.g., a KRW 417M aptamer-discovery contract in September 2025). It provides recurring, contract-based revenue and helped the company meet KOSDAQ's KRW 3bn revenue threshold in FY2025. 4. **Consumer pet nutrition (from March 2026).** Choolip Inc. is a US (California) premium pet-treat and beverage brand. It sells mainly on Amazon and its own website, with products manufactured in Korea. **Revenue model mix (latest, FY2025).** Mostly services (CRO, synthesis, discovery contracts) plus small diagnostic product sales. There is no licensing income. From FY2026, consolidated revenue should be dominated by consumer product sales via Choolip. Segment proportions are not publicly disclosed. **Value-chain position.** The company sits at the discovery and early-clinical stage in therapeutics, relies on CDMOs for GMP manufacturing (a 2022 CDMO agreement with China's Asymchem for AST-201 was reported by Daum/News1, July 2024), and acts as a service provider in bioanalysis. In pet nutrition it is a brand owner with contract manufacturing in Korea. **Customer types and end-markets.** Global and Korean pharma/biotech (licensing targets, CRO clients, custom-aptamer clients); Korean tertiary hospitals and health-screening centers (diagnostics); US pet owners via e-commerce and retail (pet nutrition).

Revenue$0.0B
Employees38
Market CapN/A
Founded2011
Seongnam, South Korea
AptaBio

AptaBio Therapeutics Inc.

Premium
Information Technology

AptaBio Therapeutics is a small-cap, clinical-stage Korean drug developer built on two proprietary discovery platforms. The first is a NADPH oxidase (NOX) inhibition platform for modulating oxidative stress. The second is an aptamer–drug conjugate (Apta-DC) platform that couples a G-quadruplex DNA aptamer with cytotoxic nucleoside drugs. The company's value is concentrated in isuzinaxib (APX-115), an oral pan-NOX inhibitor. Isuzinaxib is in Phase 2 for contrast-induced acute kidney injury (CI-AKI), where no therapy is approved, and in Phase 2b for diabetic kidney disease (DKD). Behind it sit APX-343A, a NOX-based modulator of cancer-associated fibroblasts in Phase 1 with Merck-supplied Keytruda; ABF-101, an oral wet-AMD candidate in US Phase 1; and Apta-16 for relapsed/refractory AML. Revenue (KRW 3.7 bn in FY2025) comes almost entirely from a health-functional-food ODM business added in late 2023 to meet KOSDAQ minimum-revenue rules. The equity story depends on converting the October 2026 CI-AKI readout into a licensing deal before cash runs short. --- **What the company does.** AptaBio discovers and develops first-in-class small-molecule and conjugate drugs for intractable diseases. Its pipeline uses two platforms. The NOX inhibitor platform targets NOX isozymes, the enzyme family that generates reactive oxygen species (ROS); the lead compound isuzinaxib inhibits all seven NOX isoforms. The Apta-DC platform modifies the G-quadruplex aptamer AS1411 by substituting an anti-metabolite (gemcitabine or azacitidine) at a specific nucleotide position, so the aptamer delivers the payload to cancer cells (Source: Samsung Securities initiation, 26 Dec 2019; Hankyung, 27 Apr 2026). Since 2024 the company has presented a third technology theme, cancer-associated fibroblast (CAF) modulation. In practice this is a NOX-platform application: APX-343A blocks CAF–M2 macrophage crosstalk in the tumour microenvironment (Source: Edaily, Nov 2025; company IR 2024). **Company's own description.** In its 2024 IR deck the company describes itself as a platform-based developer of first-in-class innovative drugs. It lists three focus areas (diabetic complications, intractable cancers, cancer immunotherapy) and three platforms (oxidative stress modulation, aptamer–drug conjugates, CAF modulation), under the mission phrase "Make Life Better" (Source: AptaBio IR 2024, July 2024). Its BIO International Convention exhibitor profile names Apta-DC and NOX inhibitors as its two proprietary platforms (Source: BIO 2026 exhibitor listing). **Business model and revenue model.** The model is out-licensing, not commercialisation. AptaBio aims to take assets through clinical proof-of-concept (Phase 1/2) and then license them to larger pharma for upfront payments, milestones and royalties. Historical licensing income has been small. Kiwoom (2021) and IB Tomato (2023) data show revenue of KRW 1.5 bn in FY2018 and KRW 1.0 bn in FY2019, mainly licence-related, which then fell to near zero by FY2022. To avoid KOSDAQ "administrative issue" designation (consolidated revenue below KRW 3 bn after the technology-listing grace period), the company created a New Business Division in November 2023. The division covers gene-delivery reagents, health-functional-food (HFF) ODM, and pet-care product distribution (Source: Kormedi, Dec 2023; IB Tomato, Jul 2024). By 2Q 2026, HFF ODM made up 100% of quarterly revenue (Source: Butler segment data). **Value-chain position.** Upstream discovery and early/mid-stage clinical development. Manufacturing, late-stage trials and commercialisation are expected to sit with licensees. CROs run the trials (for example, Covance on the 2021 US COVID-19 Phase 2 plan, and a Japanese non-clinical CRO for ABF-101 genotoxicity work). **Customer types and end-markets.** Prospective pharma licensees in nephrology, interventional cardiology/radiology (CI-AKI), ophthalmology (wet AMD, diabetic retinopathy), hepatology (MASH) and oncology (solid tumours, AML). Current revenue customers are Korean HFF brand owners and online retail channels (ODM), and earlier, pet owners via distribution. **Independent characterisation.** AptaBio is a pre-revenue platform biotech with a low-margin consumer-health side business that exists mainly to preserve its listing. Its scientific differentiation is real but narrow. The company says isuzinaxib is one of only two clinical-stage NOX inhibitors globally, the other being Calliditas' setanaxib (Source: Money Today/Daum, Aug 2024). Its financial position is fragile: cumulative operating losses for FY2021–FY2025 were about KRW 74 bn. Funding has relied on convertible instruments, and in 2026 cash was supplemented by selling down an affiliate stake. The October 2026 CI-AKI Phase 2 readout is the defining event for the company.

Revenue$0.0B
Employees44
Market CapN/A
Founded2009
Yongin, South Korea
Aprogen

Aprogen Inc.

Premium
Information Technology

Aprogen Inc. is a loss-making Korean biopharmaceutical holding company. It sits on top of a 55-year-old listed industrial shell, the former KIC, and its strategy rests on one technological claim: perfusion (continuous) cell-culture manufacturing at the Osong plant can produce monoclonal antibodies at a fraction of the cost of fed-batch competitors. Its lead asset is AP063, a trastuzumab (Herceptin) biosimilar. In 2026 both the EMA and the FDA indicated that AP063 could proceed toward approval without a confirmatory Phase 3, which shifts the critical path to process-validation (PPQ) manufacturing and dossier filing. Behind AP063 sit adalimumab and rituximab biosimilars, an osteoarthritis biologic (AP209), an in-licensed anti-VISTA immuno-oncology antibody (PMC-309) and, through listed subsidiary Apton, the Phase 2-complete mobiliser burixafor (GPC-100). Consolidated revenue (KRW 118bn in FY2025) still leans heavily on non-pharma businesses: hardfacing, semiconductor-equipment parts, geothermal engineering and insulation. The group depends on repeated intra-group equity and convertible-bond financing. --- ### What the company does Aprogen operates at two levels. **Parent level.** The listed entity is a bio R&D company and, since January 2025, a statutory holding company. It owns and directs the group's biologics pipeline: biosimilars and novel antibodies or fusion proteins. It also retains legacy KIC industrial activities, chiefly hardfacing (wear-resistant overlay cladding) and insulation for heavy-industry plant [S4][S38]. **Group level.** Consolidated revenue includes several listed and unlisted subsidiaries: **Aprogen Biologics:** (KOSPI: 003060; 56.9% owned): pharmaceutical sales, Osong plant CMO/CDMO, and semiconductor-equipment parts through its control of N2Tech. **Aptochrome:** (formerly AP Healthcare; 71.7%): pharmaceutical distribution. **Apton:** (KOSDAQ: 270520; formerly GeoLit Energy, then Apt Neuroscience; 31.6%): geothermal/renewable-energy engineering plus new-drug development. **KIC Industrial Machinery (Zhangjiagang) Co:** (China; 100%). [S2][S27][S33] ### Company's own description The June 2025 IR presentation describes the company as a biotech that develops commercially attractive biologics on the strength of world-class technology. Its stated main business is the development, manufacture and sale of biosimilars and novel biologics (bispecific antibodies and dual-receptor fusions). It highlights: - its 2020 designation as Korea's first bio "unicorn"; - a claimed lowest-in-world manufacturing cost; and - a proprietary, internationally registered bispecific-antibody platform. [S3] In November 2025 management restated strategy as three pillars: biosimilars (exploiting regulatory easing), innovative new drugs (immuno-oncology and osteoarthritis), and "hybrid" CMO. [S31] ### Business and revenue model | Revenue stream | Model | Status (Oct 2026) | Source | |---|---|---|---| | Biosimilar licensing / commercial supply | Licensing of sales rights to regional distributors plus supply from Osong. The company targets about a 50% price discount versus competitors. | Pre-revenue for AP063, AP096 and AP056. Infliximab biosimilar GS071 is approved in Japan (2017); its current commercial contribution is not disclosed. | [S3][S19] | | Novel drugs | Early licence-out (L/O) or co-development with global pharma | AP209 is entering Phase 1; PMC-309 is in Phase 1a/1b (Australia); GPC-100 (via Apton) is planning Phase 3 | [S3][S29][S34] | | CMO / CDMO | Fee-for-service drug substance and drug product manufacturing at Osong | The plant was approved by Korea's Ministry of Food and Drug Safety (MFDS) as a specialised biologics CMO in June 2024. One molecule was won (DS+DP) and three were under negotiation as of mid-2025. | [S3][S25] | | Pharmaceutical sales / distribution | Trading margin | Revenue-generating (43% of the 2Q26 mix with all pharma combined) | [S4] | | Hardfacing | Industrial service/product (legacy KIC) | Revenue-generating (23% of mix) | [S4] | | Semiconductor-equipment parts | Manufacturing (N2Tech) | Revenue-generating (22% of mix) | [S4][S27] | | Renewable energy (geothermal) | Engineering (Apton) | Revenue-generating (10% of mix) | [S4][S34] | | Insulation | Industrial (legacy KIC; LNG/plant) | Revenue-generating (3% of mix) | [S4] | Product versus service versus licensing mix: on the 2Q26 mix, roughly 43% is pharmaceutical (mostly product and distribution sales) and about 58% is industrial product or engineering revenue. The rows sum to 101% because of source rounding. Licensing revenue is not separately disclosed and appears immaterial. ### Value-chain position, customers and end-markets | Area | Customers / end-markets | |---|---| | Biosimilar partners | Regional pharmaceutical distributors (Europe, US) | | CDMO clients | Biopharma sponsors, including European companies and group affiliates (e.g. Apton's Parkinson's programme) | | Therapeutic areas | Oncology (HER2+ breast cancer, haematological malignancy), autoimmune/inflammatory disease, osteoarthritis, neurodegeneration | | Industrial customers | Steel, petrochemical, shipbuilding, power-generation and LNG plant operators (KIC heritage) | | Semiconductor customers | Semiconductor-equipment supply chain (N2Tech) | In biologics, Aprogen is vertically integrated from cell-line development through drug substance and drug product. Its stated strength is the upstream step, where it combines high-titre cell lines with perfusion culture. It relies on partners for clinical execution (e.g. Syneos as CRO for the AP063 Phase 3) and for commercial distribution [S3][S19]. [S25][S38] ### Independent characterisation Aprogen is best understood as a high-burn, pre-commercial biosimilar platform bolted onto a listed industrial shell. It is surrounded by a web of listed affiliates whose capital raises circulate within the group. The economic thesis is real and specific. Perfusion at 2,000L working volume is claimed to yield 92–200 kg of antibody per batch, against roughly 30–60 kg for a 12,000–15,000L fed-batch run. If that holds at commercial scale under cGMP, it supports aggressive price-led entry into mature biosimilar molecules. The execution record is weak, however: - no Western approvals after more than two decades; - operating losses of KRW 87–119bn every year from FY2021 to FY2025; - market value down well over 90% from 2022 levels; and - persistent press scrutiny of related-party funding loops. [S1][S3][S27][S35]

Revenue$0.1B
Employees625
Market CapN/A
Founded1971
Seongnam, South Korea
Aprogen

Aprogen Healthcare & Games Inc.

Premium
Information Technology

APTOCROM is a very small KOSDAQ-listed company inside the Aprogen biopharmaceutical group, which is controlled by Kim Jae-seop through his holding company G-Base. Its stated operating businesses are wholesale and retail distribution of pharmaceuticals (dermatologicals, gastrointestinal drugs, tonics and antibiotics) and leasing of owned real estate, machinery and equipment. Group-level reporting since 2020 has described its function as sales of pharmaceuticals and asset leasing. In practice, its economic profile is dominated by its role as a group financing vehicle rather than by operations. It carries a balance sheet of roughly KRW 320 bn against annual revenue under KRW 10 bn. It has channeled large sums into parent Aprogen's biosimilar programs: KRW 50 bn to trastuzumab biosimilar AP063 in 2023 and a KRW 70 bn cost-sharing commitment to adalimumab biosimilar AP096 in 2024. In August 2025 it added blockchain and virtual-asset activities to its articles of incorporation. Its equity story therefore turns on related-party asset recovery rather than on distribution economics. --- ### Company's own description (from filings) The Q1 2026 quarterly report filed on KIND describes the company (formerly AP Healthcare) as founded in February 1998 and engaged in pharmaceutical wholesale/retail and leasing (KIND Q1 2026 report, filed 14 May 2026). An August 2025 Asia Economy article summarizing disclosures was more specific. It described the pharmaceutical business as distribution and sale centered on external-use (dermatological) preparations, digestive-system drugs, tonics/nutritional preparations and antibiotic preparations. It described the leasing business as rental of owned real estate, machinery and equipment (Asia Economy, 11 Aug 2025). ### Business model and revenue model | Dimension | Characterization | Basis | |---|---|---| | Revenue model | Predominantly product resale (merchandise distribution) plus rental income; no subscription or licensing revenue disclosed | Filing descriptions, 2025–2026 | | Product vs. service mix | Product distribution plus leasing; exact split not publicly disclosed in sources reviewed | — | | Value-chain position | Downstream intermediary (wholesale/retail) in Korean pharmaceutical distribution; asset lessor | Filings | | Customer types | Not publicly disclosed (typical counterparties for Korean pharmaceutical wholesalers are pharmacies; clinics and hospitals) | — | | End-markets | South Korean domestic pharmaceutical market; domestic commercial real-estate rental (Seongnam) | Filings; KIND asset tables | | Related-party economic interests | Revenue-linked "dividend" rights on AP096 (adalimumab biosimilar) under a KRW 70 bn cost-sharing contract with Aprogen; prior KRW 50 bn funding of AP063 (trastuzumab biosimilar); holdings of Aprogen convertible bonds | Dealsite, 20 Sep 2024; NewDaily, 23 Sep 2024; DigitalToday, 31 Mar 2026 | | New statutory business objectives | Blockchain and virtual-asset business, blockchain/virtual-asset investment, blockchain/virtual-asset finance, and ancillary services/installation, added at the 22 Aug 2025 EGM | Asia Economy, 11 Aug 2025 | ### Legacy businesses (pre-2024) Before it became a pure distribution/leasing entity, the company (as Aprogen H&G) was described by aggregators as a mobile-game publisher that also provided domestic wireless lighting-control services and telecommunications/wireless solutions (Morningstar; CB Insights). Statbase's legacy management list includes a head of a Light Control Division, a head of a Wireless Solution Business Division and an R&D Center chief, consistent with that profile. The largest legacy game title was the mobile game Fortress M. Its publishing contract was terminated early in February 2021, removing about KRW 7.6 bn of sales; the then-parent Aprogen Pharmaceuticals said this equalled 15% of its own consolidated revenue. Management said it would offset the gap by publishing Trove and Dragon Raja Origin and further titles (Asia Economy English, 19 Feb 2021). The FY2025 revenue decline was attributed only to a "slowdown in a subsidiary's business," and the subsidiary was not named in the excerpts reviewed (FY2025 earnings-variance disclosure, 27 Feb 2026). ### Independent characterization On the numbers, APTOCROM's operating businesses are sub-scale. Consolidated FY2025 revenue was KRW 9.81 bn with an operating loss of KRW 2.29 bn, against total assets of about KRW 320 bn (FY2025 audited summary, 30 Mar 2026). An asset-to-revenue ratio above 30x means the operating business is not the main driver of value. What drives value is the recoverability of (i) related-party claims on Aprogen biosimilar programs, (ii) Aprogen-issued securities (such as the KRW 40 bn 27th-series CB it is selling), and (iii) its Seongnam real estate. Analytically, it behaves like a captive treasury or holding vehicle of the Aprogen group, with a small distribution business attached. The renaming to APTOCROM alongside a crypto/blockchain charter amendment fits a 2025 KOSDAQ pattern: other small caps such as Hyper Corporation, Parataxis Korea and Someage saw share-price spikes after announcing virtual-asset pivots (Asia Economy, 11 Aug 2025). No operating crypto revenue has been disclosed.

Revenue$0.0B
Employees18
Market CapN/A
Founded1998
Seongnam, South Korea
Apoorva

Apoorva Leasing Finance & Inve

Premium
Information Technology

Apoorva Leasing Finance and Investment Company Limited is a 43-year-old, Delhi-incorporated, Noida-operated micro-cap investment company that deploys a roughly INR 145 Cr equity base into listed and unlisted equities, mutual funds, debt instruments, loans and related-party vehicles. Despite the "leasing" in its name, it has no visible leasing franchise today; its revenue is almost entirely interest and dividend income plus episodic trading gains, and it reports a single segment, "Financing and Derivatives". The company is controlled (52.66%) by Times Capital Services Pvt. Ltd. and Managing Director Atul Singh Tyagi, has no institutional shareholders, no borrowings, roughly ten employees, and has never paid a dividend. Revenue has contracted from a peak of INR 21.83 Cr (FY2020) to INR 1.37 Cr (FY2026), and return on equity has fallen to about 0.2%. The stock trades near 0.47x book, reflecting the market's discount on low returns, opaque asset composition and governance turnover — notably three statutory-auditor changes in four years. --- ### The company's own description The company describes itself on its website as a BSE-listed company (scrip 539545), incorporated on 7 October 1983, whose business is investing in equity, debentures, bonds, mutual funds and similar instruments. Its website tagline is "Building Value Through Strategic, Diversified Investments." The website elaborates an investment philosophy that blends growth investing (companies with strong earnings potential and scalable models) with value investing (fundamentally sound companies trading below intrinsic value), and lists target asset classes as listed and unlisted equity, debt and fixed-income securities, structured financial products, and "emerging sector" and alternative opportunities. It claims to manage both short-term tactical positions and long-term holdings, supported by fundamental and technical analysis, risk-adjusted return evaluation and portfolio rebalancing. The FY2025 Board's Report (signed 3 September 2025) states there was no change in the nature of business, describes the company as an investment company engaged in investing in securities available in the market, and explains that it does not need large human resources because its primary activity is investing. Exchange data providers (S&P Global via StockAnalysis/PitchBook) record the company's only operating segment as "Financing and Derivatives," and the Screener summary (sourced to the FY2025 annual report) describes the company as dealing in financing and derivatives activities. A boilerplate description carried by MarketsMojo and mStock (C-MOTS-sourced) says the company has diversified into third-party product distribution and originating unsecured personal and corporate loans. ### Independent characterisation In practice, Apoorva is a closely held proprietary investment vehicle wrapped in a listed shell. The economic engine is the balance sheet, not an operating business: **Asset base:** Total standalone assets of INR 158.71 Cr at 31 March 2026, funded almost entirely by equity (INR 145.28 Cr net worth) and INR 13.43 Cr of "other liabilities" (Screener, FY2026). **Revenue model:** ~98–99% of consolidated revenue in FY2025–FY2026 was interest and dividend income (StockAnalysis/S&P: FY2026 interest & dividend income INR 13.51 M of INR 13.69 M revenue). In earlier years (FY2019–FY2022), revenue was inflated by sale of shares/commodities — consolidated "cost of services provided" was INR 22.24 M in FY2022 and INR 9.93 M in FY2023, collapsing to INR 0.09 M in FY2026 — indicating the trading book has effectively wound down. **Product/service vs. subscription/licensing mix:** Not applicable. There is no product, subscription or licensing revenue. The mix is approximately: interest/dividend income ~99%, other revenue ~1% (FY2026 consolidated). **Value-chain position:** A capital provider/investor at the end of the chain; it neither originates retail credit at scale nor intermediates third-party funds. **Customer types:** Borrowers and investee companies (including subsidiaries, associates and an LLP); identities not fully disclosed. **End-markets:** Indian capital markets (listed equities, mutual funds) and private/unlisted Indian companies. 100% domestic. **Regulatory status:** MarketsMojo classifies it as an NBFC; an RBI Certificate of Registration number was not publicly verifiable in the sources reviewed. The AGM of 30 September 2025 approved a borrowing limit of INR 250 Cr and creation of charges (Screener announcement summary), an enabling resolution far larger than the current nil-debt balance sheet.

Revenue$0.0B
Employees10
Market CapN/A
Founded1983
Noida, India

Page 86 of 482

1…858687…482

Page 86 of 482

Go to page
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo